It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited Researchers^TM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

Abate, Antonio Abatzoglou, John T. Abbaszadeh, Mostafa Acharya, U. Rajendra Acharya, Viral V. Agarwal, Ravi P. Ahn, Myung-Ju Airoldi, Laura Ali, Imran Aluko, Rotimi E. Anasori, Babak Andersson, Dan I. Andes, David Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Arqub, Omar Abu Aschner, Michael Assaraf, Yehuda G. Astruc, Didier Atala, Anthony Atanasov, Atanas G. Atangana, Abdon Bahram, Mohammad Bakris, George L. Balandin, Alexander A. Baleanu, Dumitru Balsamo, Gianpaolo Bando, Yoshio Banks, William A. Bansal-Travers, Maansi Barba, Francisco J. Barros, Lillian Basit, Abdul W. Baskonus, Haci Mehmet Bassetti, Matteo Battino, Maurizio Bell, Jordana T. Bellomo, Nicola Benediktsson, Jon Atli Benelli, Giovanni Benjakul, Soottawat Bhatnagar, Amit Biddle, Stuart J. H. Biondi, Antonio Biondi-Zoccai, Giuseppe Bjarnsholt, Thomas Blaabjerg, Frede Blaschke, Thomas Blay, Jean-Yves Blumwald, Eduardo Blunt, John W. Boffetta, Paolo Bogers, Marcel Bonomo, Robert A. Boyer, Cyrille Brestic, Marian Brevik, Eric C. Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cai, Xingjuan Cai, Jianchao Calhoun, Vince D. Calin, George Cao, Jinde Cao, Guozhong Carvalho, Andre F. Castellanos-Gomez, Andres Cerqueira, Miguel Ângelo Parente Ribeiro Chang, Jo-Shu Chang, Chih-Hao Chastin, Sebastien Chau, Kwok-wing Chemat, Farid Chen, Xiaobo Chen, YangQuan Chen, Jianmin Chen, Chaoji Chen, Min Chen, Qi Chen, Jun Chen, Xi Chen, Peng Chen, Yulin Chen, Bo Chen, Chen Chen, Zhi-Gang Chen, Wei-Hsin Chen, Gang Chen, Yongsheng Chen, Xiang Chen, Yimin Chen, Runsheng Chen, Lidong Chen, Shaowei Chen, Qian Chen, Yu Chen, Shuangming Chiclana, Francisco Cho, Sun Young Choi, Wonyong Chowdhary, Anuradha Choyke, Peter L. Cichocki, Andrzej Corella, Dolores Corma, Avelino Cortes, Javier Cortes, Jorge Costanza, Robert Crommie, Michael F. Cui, Yi Cui, Haiying Cui, Qinghua Cummings, Kenneth Michael Dai, Shifeng Dai, Sheng Daiber, Andreas Davis, Steven J. Dawson, Ted M. de la Fuente-Nunez, Cesar Decker, Eric Andrew Dekel, Avishai Demaria, Marco Deng, Yong Deng, Xiangzheng DePinho, Ronald A. Desneux, Nicolas Dimopoulos, Meletios-Athanasios Ding, Aijun Dionysiou, Dionysios D. Dokmeci, Mehmet Remzi Dolgui, Alexandre Dong, Fan Dou, Shi Xue Dou, Letian Du, Qian Du, Bo Dube, Shanta Rishi Dufresne, Alain Dummer, Reinhard Dupont, Didier Edwards, David Elaissari, Abdelhamid Elhoseny, Mohamed Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estévez, Mario Fabbro, Doriano Facchetti, Antonio Fan, Zhanxi Fang, Chuanglin Fasano, Alessio Fečkan, Michal Felser, Claudia Feng, Liangzhu Fensholt, Rasmus Ferdinandy, Péter Fernandez-Lafuente, Roberto Ferreira, Isabel C. F. R. Filippi, Massimo Fisher, Helen Fortino, Giancarlo Fosso Wamba, Samuel Franceschi, Claudio Fujita, Hamido Fujita, Masayuki Gai, Francesco Gaisford, Simon Galanakis, Charis M. Galluzzi, Lorenzo Galvano, Fabio Gan, Ren-You Gan, Lihua Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Minrui Gao, Huijun Gao, Wei Gao, Huile Garbe, Claus Garcia, Hermenegildo Gasbarrini, Antonio Gasco, Laura Gautret, Philippe Geng, Yong Gerdts, Gunnar Geschwind, Daniel H. Ghadimi, Noradin Ghaffari, Roozbeh Ghamisi, Pedram Giampieri, Francesca Glick, Bernard R. Gnant, Michael Goel, Ajay Gogotsi, Yury Goldewijk, Kees Klein Gong, Jinlong Gong, Yongji Govindan, Kannan Granato, Daniel Grancini, Giulia Green, Douglas R. Grosso, Giuseppe Gu, Ke Guan, Cao Guastella, Adam J. Guerrero, Josep M. Gui, Guan Guizani, Mohsen Guo, Zaiping Gupta, Rangan Gutzmer, Ralf Haase, Dagmar Habibi-Yangjeh, Aziz Hagemann, Stefan Hagger, Martin Hamblin, Michael R. Hammoudeh, Shawkat Han, Heesup Hanes, Justin Harrison, Roy M. Hartung, Hans-Peter Hasanuzzaman, Mirza He, Jr-Hau He, Hongwen He, Jiaqing He, Debiao Henseler, Jörg Herrera, Francisco Herrera-Viedma, Enrique Hetz, Claudio Ho Kim, Jung Holmes, Elaine Hossain, Ekram Hsueh, Po-Ren Hu, Xiaosong Hu, Wenbin Huang, Jianping Huang, Hongwei Huang, Yu Huang, Jianying Huang, Peng

Huang, Baibiao Huang, Shaoming Hubacek, Klaus Iqbal, Hafiz M. N. Ismail, Ahmad Fauzi Izzo, Angelo A. Jacobson, Kenneth A. Jain, Atul Jankovic, Joseph Jelezko, Fedor Ji, Xiaobo Ji, Guangbin Jiang, Hai-Long Jiang, Lei Jiang, Junjun Jiang, Qing Jiang, Shibo Jin, Shi Jones, Peter A. Kalantar-zadeh, Kourosh Kaner, Richard B. Kannan, Kurunthachalam Kappos, Ludwig Karagiannidis, George K. Karimi, Hamid Reza Karimi-Maleh, Hassan Karp, Peter D. Kataoka, Kazunori Katritch, Vsevolod Kawi, Sibudjing Keesstra, Saskia Kepp, Oliver Keyzers, Robert A. Khademhosseini, Ali Khan, Nafees A. Kiessling, Fabian Kim, Ki-Hyun Kim, Haegyeom Kim, Jeonghun Kim, Jong Seung Kirkwood, John M. Kisi, Ozgur Kivshar, Yuri Klenk, Hans-Peter Ko, Wen-Chien Konopleva, Marina Y. Kontoyiannis, Dimitrios P. Koonin, Eugene V. Kou, Gang Krausmann, Fridolin Krebs, Frederik C. Kroemer, Guido Kuca, Kamil Kudo, Masatoshi Kuhn, Jens H. Kumar, Devendra Kumar, Alan Prem Kumar, Sudhir Kumar Sangaiah, Arun Kurths, Juergen Kuznetsov, Nikolay V. Kuzyakov, Yakov Kwan, Mei-Po Kyrpides, Nikos C. La Vecchia, Carlo Lai, Yuekun Lam, James Lammers, Twan Lamuela-Raventos, Rosa M. Lancellotti, Patrizio Landi, Francesco Laurent, Sophie Lavie, Carl J. Laxminarayan, Ramanan Lee, Sang Soo Lee, Jin-Wook Lee, Pooi See Lehmann, Johannes Lei, Yaguo Lei, Ting Leng, Lijian Leung, Dennis Y. C. Leung, Victor C. M. Levine, Ross Li, Wei Li, Jie Li, Jinghong Li, Jun Li, Heng Li, Gang Li, Yat Li, Peng Li, Hailong Li, Changpin Li, Yan Li, Yurui Li, Xiaodi Li, Hong Li, Shutao Li, Hongyi Li, Zhijun Li, Peiyue Lin, Yuehe Lin, Hongjun Lin, Lin Lip, Gregory Y. H. Liu, Jian Liu, Meng Liu, Hong Liu, Tao Liu, Lei Liu, Jianxing Liu, Wei Liu, Gang Liu, Yang Liu, Peide Lockhart, Shawn R. Long, Hualou Löscher, Wolfgang Lu, Jun Lu, Jianquan Lu, Nanshu Lucey, Brian Luigi Russo, Gian Lund, Henrik Luo, Jun Luo, Yi Luo, Jingshan Luo, Yangchao Lupton, Deborah Luque, Rafael Lv, Wei Lvov, Yuri M. Lyons, Timothy W. Ma, Tianyi Ma, Jun Ma, Jiayi Ma, Wen-Xiu Ma, Yanming Maggioni, Aldo Pietro Mahmood, Nasir Mahmoudi, Morteza Mai, Liqiang Mallavarapu, Megharaj Mandala, Mario Mardani, Abbas Marengo, Jose Maria Rossolini, Gian Martinoia, Enrico Mathiesen, Brian Vad Mathivanan, Suresh Mattick, John S. Matyjaszewski, Krzysztof McCabe, Matthew E. McCauley, Darren McClements, David Julian Melcher, Karsten Melenhorst, Jan Joseph Melero, Ignacio Mezzetti, Bruno Mirjalili, Seyedali Mishchenko, Artem Mittler, Ron Moreau, Philippe Motohashi, Hozumi Mousavi Khaneghah, Amin Mu, Shichun Mueller, Lukas A. Mueller-Roeber, Bernd Muenzel, Thomas Muhammad, Khan Munger, J. William Nauen, Ralf Naushad, Mu. Negri, Eva Nemeroff, Charles B. Newman, David J. Niaura, Raymond S. Nie, Feiping Nieto, Juan J. Novara, Agata Nunkoo, Robin Ogino, Shuji Olabi, Abdul-Ghani Ong, Hwai Chyuan O'Regan, Donal Orsini, Nicola Ouyang, Minggao Ozcan, Aydogan Pacher, Pal Pan, Xiaoqing Pan, Likun Pan, Quan-Ke Pang, Huan Pavela, Roman Pedrycz, Witold Pei, Yanzhong Peng, Shushi Peng, Qing Peng, Mugen Perc, Matjaz Perez-Alvarez, Jose Angel Perlin, David S. Piquero, Alex R. Polasky, Stephen Pommier, Yves Poor, H. Vincent Postolache, Mihai Potenza, Marc N. Poulter, Benjamin Preat, Veronique Prinsep, Michele R. Pu, Hong-Bin Putnik, Predrag Qiu, Jieshan Qu, Xiaogang Quiles, José L. Rabczuk, Timon Ramakrishna, Seeram Ramkissoon, Haywantee Ran, Jingrun Recio, Isidra Reiter, Russel J. Remuzzi, Giuseppe Ren, Jinsong Ren, Jun Riahi, Keywan Richardson, Paul G. Rignot, Eric Rimm, David Rinn, John L. Robert, Caroline Rodriguez, Rosa M. Rojo, Teofilo Ros, Emilio Rosen, Marc A. Roubaud, David Russo, Alessandro Saad, Fred Saad, Walid Sadorsky, Perry Sander, Chris Santamouris, Mattheos Santoro, Gabriele

Saraiva, Jorge A. Sarchiapone, Marco Scalbert, Augustin Schloter, Michael Schneider, Gisbert Schubert, Ulrich S. Schulz, Rainer Schwab, Matthias Schweizer, Frank Scolyer, Richard A. Scorrano, Luca Scott, David Scott, Stuart A. Scott, Daniel Serra-Majem, Lluis Sethi, Gautam Shabala, Sergey Shaheen, Sabry M. Shao, Zongping Sharma, Gaurav Shen, Guozhen Shen, Hao Sheremet, Mikhail A. Shi, Peng Shi, Yumeng Shoenfeld, Yehuda Siano, Pierluigi Sillanpaa, Mika Simões, Manuel Simpson, Richard J. Singh, Bhupinder Pal Singh, Vijay P. Smagghe, Guy Song, Yu Song, Houbing Sood, Anil K. Srivastava, Hari M. Stadler, Marc Stadler, Peter F. Stanley, H. Eugene Stoumpos, Constantinos C. Strano, Michael S. Stunnenberg, Hendrik G. Su, [email protected] Su, Chun-Yi Subramanian, S. V. Sun, Zhipei Sun, Fengchun Sun, Hongqi Sunderland, Elsie M. Suzuki, Nobuhiro Svenning, Jens-Christian Szabo, Csaba Szallasi, Arpad Szolnoki, Attila Tacke, Frank Tan, Weihong Tan, Chaoliang Tang, Hua Tang, Chuyang Tang, Chuan-He Tanzi, Rudolph E. Teichmann, Sarah Telenti, Amalio Thakur, Vijay Kumar Thiele, Holger Tian, Jie Tohge, Takayuki Tran, Lam-Son Phan Truhlar, Donald G. Tsao, Rong Tsuda, Kenichi Tukker, Arnold Tung, Chen-Ho Turskis, Zenonas Urquhart, Andrew Valko, Marian Van Breusegem, Frank Van de Wiele, Tom van der Werf, Guido van Wesemael, Bas Vangronsveld, Jaco Varma, Rajender S. Varsani, Arvind Varshney, Rajeev K. Vasilakis, Nikos Vasilakos, Athanasios V. Vasquez, Juan C. Vatanen, Tommi Ventura, Marco Vermote, Eric Veronese, Nicola Verpoorte, Robert Vethaak, A. Dick Vieta, Eduard Vincent, Jean-Louis Wagner, Wolfgang Walton, Vaughn M. Wan, Jiafu Wan, Shaohua Wang, Qi Wang, Joseph Wang, Meng Wang, Tao Wang, Yuan Wang, Xin Wang, Chao Wang, Yong Wang, Jun Wang, Erkang Wang, Sibo Wang, Jian Wang, Ning Wang, John Wang, Qin Wang, Shaojian Wang, Guoxiu Wang, Huanting Wang, Chunsheng Wang, Gongming Wang, Zhong Lin Wang, Lianzhou Wang, Shaobin Wang, Yang Wang, Zifa Wei, Zhixiang Wei, Leyi Weissleder, Ralph Wen, Guanghui Wiens, John J. Wigneron, Jean-Pierre Willerslev, Eske Wishart, David S. Witlox, Frank Wu, Jun Wu, Tom Wu, Hao Bin Wu, Hui Wu, Haijun Wu, Zhongbiao Wu, Zhong-Shuai Wu, Zheng-Guang Xia, Meimei Xia, Xinhui Xiang, Quanjun Xiao, Jianbo Xiao, Jie Xie, Jian-Hua Xin, Sen Xing, Baoshan Xiong, Rui Xu, Bin Xu, Li Da Xu, Yi-Jun Xu, Hui Xu, Zeshui Yamauchi, Yusuke Yan, Huaicheng Yan, Kai Yang, Chenguang Yang, Xiao-Jun Yang, Bing Yang, Yun-Gui Yang, Jie Yang, Jian Yang, Xinsong Yang, Shihe Yang, Yi Yang, Yang Yao, Jen-Chih Yao, Yonggang Yazyev, Oleg Yin, Yulong Yin, Zongyou Yin, Shen Yin, Ya-xia Yin, Shou-Wei Ying, Guang-Guo Young, Allan H. Yu, Shu-Hong Yu, Jun Yu, Guihua Yu, Wenwu Yu, Guocan Yu, Minghao Zarco-Tejada, Pablo J. Zavadskas, Edmundas Kazimieras Zeadally, Sherali Zhai, Tianyou Zhang, Wei Zhang, Binlin Zhang, Shujun Zhang, Guoping Zhang, Zengqiang Zhang, Yu Shrike Zhang, Qichun Zhang, Xian-Ming Zhang, Guowen Zhang, Min Zhang, Yue-Jun Zhang, Shaoqing Zhang, Fan Zhang, Weili Zhang, Xiaodong Zhang, Zhien Zhang, Tierui Zhang, Hongjie Zhang, Dengsong Zhang, Liangpei Zhang, Dan Zhang, Yu-Dong Zhang, Fusuo Zhao, Yi Zhao, Guochun Zhao, Li-Dong Zheng, Hao Zheng, Gengfeng Zhong, Cheng Zhou, Weiqi Zhou, Qi Zhou, Jizhong Zhu, Hongwei Zhu, Chengzhou Zhu, Junfa Zhu, Zhe Zhu, Quanxin Zhuang, Xiaodong Zhuang, Xiaoying Zou, Quan

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of Science^TM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

• Have expertise and experience in the field related to the journal;
• Have received a Ph.D. in the last 10 years, approximately;
• Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
• Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

• 25 October 2021
  Energies journal and Institute of Mechanics, Chinese Academy of Sciences

• 28 October 2021
  Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University

• 29 October 2021
  Processes journal and Beijing Institute of Technology

• 29 October 2021
  Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

• Adriana Burlea-Schiopoiu;
• Alban Kuriqi;
• Álvaro González-Vila;
• Alessandro Alaimo;
• Alexey Beskopylny;
• Alexander Yu Churyumov;
• Alberto Fernández-Isabel;
• Andrea Mastinu;
• Antonios N. Papadopoulos;
• Anton Rassõlkin;
• Antonio Humberto Hamad Minervino;
• Arkadiusz Matwijczuk;
• Artur Słomka;
• Baojie He;
• Bartłomiej Potaniec;
• Bojan Đurin;
• Camilo Arturo Rodriguez Diaz;
• Carmelo Maria Musarella;
• Chiachung Chen;
• Chiman Kwan;
• Cristian Busu;
• Danil Pimenov;
• Dan-Cristian Dabija;
• Delfín Ortega-Sánchez;
• Demetrio Antonio Zema;
• Denis Butusov;
• Elena Lucchi;
• Gaurab Dutta;
• Livia Anastasiu;
• M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
[email protected]

We are pleased to announce that JCM (ISSN: 2077-0383) has established a new collaboration with the European Independent Foundation in Angiology/Vascular Medicine (VAS). It is a non-profit scientific organization that has been working on vascular diseases and their prevention for 30 years. Members can enjoy discounts for their submissions.

Other affiliated societies of JCM can be found at the following link: https://www.mdpi.com/journal/jcm/societies.

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

In July 2021, the Japan Association for Clinical Engineers (JACE) became affiliated with JCM, As part of this collaboration, all members of the JACE enjoy a discount on the article processing charge (APC) when submitting articles to the journal.

JACE was founded as a voluntary organization in February 1990. It has, through its role as an association for professionals specializing in the operation, maintenance, and inspection of life-support systems directly linked to human life, strived constantly to create a system in which patients can receive highly advanced engineering-based medical care safely with the effective use of limited medical resources. In a bid to accomplish its ocial mission, expand the duties, and raise the status of clinical engineers, it was approved as a public-interest corporation by the Ministry of Health, Labor, and Welfare (MHLW) on March 14, 2002.

The objective of this association is to contribute to the promotion and development of the nation’s medical care and welfare through the raising of professional ethics of clinical engineers, enhancement of their professional knowledge and skills, and improvement of reliability of equipment-based medical care and welfare, including life-support systems.

To aim at the global standard, JACE established “World Association for Clinical Engineers” or WACE (tentative name) and organized its first convention in Japan. For more information, please see: https://www.ja-ces.or.jp/.

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

• 10 journals received their first impact factor
• 96% of journals increased their impact factor from 2019
• 32 journals (38%) ranked among the top 25% of journals, in at least one category

Journal	Impact Factor	Rank	Category
Cancers	6.639	Q1	• Oncology
Cells	6.600	Q2	• Cell Biology
Pharmaceutics	6.321	Q1	• Pharmacology & Pharmacy
Antioxidants	6.313	Q1	• Food Science & Technology
			• Biochemistry & Molecular Biology
			• Chemistry, Medicinal
Biomedicines	6.081	Q1	• Medicine, Research & Experimental
			• Pharmacology & Pharmacy
			• Biochemistry & Molecular Biology
International Journal of Molecular Sciences	5.924	Q1	• Biochemistry & Molecular Biology
		Q2	• Chemistry, Multidisciplinary
Pharmaceuticals	5.863	Q1	• Pharmacology & Pharmacy
			• Chemistry, Medicinal
Journal of Fungi	5.816	Q1	• Mycology
			• Microbiology
Nutrients	5.719	Q1	• Nutrition & Dietetics
Biosensors	5.519	Q1	• Chemistry, Analytical
			• Instruments & Instrumentation
		Q2	• Nanoscience & Nanotechnology
Marine Drugs	5.118	Q1	• Chemistry, Medicinal
			• Pharmacology & Pharmacy
Biology	5.079	Q1	• Biology
Nanomaterials	5.076	Q1	• Physics, Applied
		Q2	• Chemistry, Multidisciplinary
			• Materials Science, Multidisciplinary
			• Nanoscience & Nanotechnology
Viruses	5.048	Q2	• Virology
Journal of Personalized Medicine	4.945	Q1	• Medicine, General & Internal
			• Health Care Sciences & Services
Metabolites	4.932	Q2	• Biochemistry & Molecular Biology
Biomolecules	4.879	Q2	• Biochemistry & Molecular Biology
Remote Sensing	4.848	Q1	• Geosciences, Multidisciplinary
		Q2	• Remote Sensing
			• Imaging Science & Photographic Technology
			• Environmental Sciences
Gels *	4.702	Q1	• Polymer Science
Antibiotics	4.639	Q2	• Infectious Diseases
			• Pharmacology & Pharmacy
Toxins	4.546	Q1	• Toxicology
			• Food Science & Technology
Vaccines	4.422	Q2	• Immunology
			• Medicine, Research & Experimental
Molecules	4.412	Q2	• Chemistry, Multidisciplinary
			• Biochemistry & Molecular Biology
Foods	4.350	Q2	• Food Science & Technology
Polymers	4.329	Q1	• Polymer Science
Journal of Clinical Medicine	4.242	Q1	• Medicine, General & Internal
Toxics	4.146	Q2	• Toxicology
			• Environmental Sciences
Catalysts	4.146	Q2	• Chemistry, Physical
Microorganisms	4.128	Q2	• Microbiology
Membranes	4.106	Q1	• Polymer Science
		Q2	• Engineering, Chemical
			• Materials Science, Multidisciplinary
			• Chemistry, Physical
Genes	4.096	Q2	• Genetics & Heredity
Fermentation *	3.975	Q2	• Biotechnology & Applied Microbiology
Journal of Cardiovascular Development and Disease *	3.948	Q2	• Cardiac & Cardiovascular Systems
Plants	3.935	Q1	• Plant Sciences
Life	3.817	Q2	• Biology
Diagnostics	3.706	Q2	• Medicine, General & Internal
Current Oncology	3.677	Q3	• Oncology
Materials	3.623	Q1	• Metallurgy & Metallurgical Engineering
		Q2	• Materials Science, Multidisciplinary
			• Chemistry, Physical
			• Physics, Applied
			• Physics, Condensed Matter
Sensors	3.576	Q1	• Instruments & Instrumentation
		Q2	• Chemistry, Analytical
			• Engineering, Electrical & Electronic
Pathogens	3.492	Q2	• Microbiology
Agronomy	3.417	Q1	• Agronomy
			• Plant Sciences
Chemosensors	3.398	Q2	• Instruments & Instrumentation
			• Chemistry, Analytical
		Q3	• Electrochemistry
Land	3.398	Q2	• Environmental Studies
Brain Sciences	3.394	Q3	• Neurosciences
International Journal of Environmental Research and Public Health	3.390	Q1	• Public, Environmental & Occupational Health (SSCI)
		Q2	• Public, Environmental & Occupational Health (SCIE)
			• Environmental Sciences (SCIE)
Tomography	3.358	Q2	• Radiology, Nuclear Medicine & Medical Imaging
Fractal and Fractional *	3.313	Q1	• Mathematics, Interdisciplinary Applications
Sustainability	3.251	Q2	• Environmental Sciences (SCIE)
			• Environmental Studies (SSCI)
		Q3	• Green & Sustainable Science & Technology (SCIE)
			• Green & Sustainable Science & Technology (SSCI)
Water	3.103	Q2	• Water Resources
			• Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research	3.049	Q3	• Business
Energies	3.004	Q3	• Energy & Fuels
Agriculture	2.925	Q1	• Agronomy
ISPRS International Journal of Geo-Information	2.899	Q2	• Geography, Physical
			• Computer Science, Information Systems
		Q3	• Remote Sensing
Micromachines	2.891	Q2	• Instruments & Instrumentation
			• Physics, Applied
		Q3	• Chemistry, Analytical
			• Nanoscience & Nanotechnology
Coatings	2.881	Q2	• Materials Science, Coatings & Films
			• Physics, Applied
		Q3	• Materials Science, Multidisciplinary
Children	2.863	Q2	• Pediatrics
Processes	2.847	Q3	• Engineering, Chemical
Separations	2.777	Q3	• Chemistry, Analytical
Insects	2.769	Q1	• Entomology
Animals	2.752	Q1	• Agriculture, Dairy & Animal Science
			• Veterinary Sciences
Symmetry	2.713	Q2	• Multidisciplinary Sciences
Atmosphere	2.686	Q3	• Meteorology & Atmospheric Sciences
			• Environmental Sciences
Applied Sciences	2.679	Q2	• Engineering, Multidisciplinary
			• Physics, Applied
		Q3	• Chemistry, Multidisciplinary
			• Materials Science, Multidisciplinary
Photonics	2.676	Q2	• Optics
Buildings *	2.648	Q2	• Construction & Building Technology
			• Engineering, Civil
Healthcare	2.645	Q2	• Health Policy & Services (SSCI)
		Q3	• Health Care Sciences & Services (SCIE)
Minerals	2.644	Q2	• Mining & Mineral Processing
			• Mineralogy
			• Geochemistry & Geophysics
Forests	2.634	Q1	• Forestry
Crystals	2.589	Q2	• Crystallography
		Q3	• Materials Science, Multidisciplinary
Entropy	2.524	Q2	• Physics, Multidisciplinary
Diversity	2.465	Q2	• Biodiversity Conservation
		Q3	• Ecology
Journal of Marine Science and Engineering	2.458	Q2	• Oceanography
			• Engineering, Marine
			• Engineering, Ocean
Medicina	2.430	Q2	• Medicine, General & Internal
Machines *	2.428	Q2	• Engineering, Mechanical
		Q3	• Engineering, Electrical & Electronic
Electronics	2.397	Q3	• Engineering, Electrical & Electronic
			• Computer Science, Information Systems
			• Physics, Applied
Fishes *	2.385	Q2	• Fisheries
			• Marine & Freshwater Biology
Metals	2.351	Q2	• Metallurgy & Metallurgical Engineering
		Q3	• Materials Science, Multidisciplinary
Horticulturae *	2.331	Q1	• Horticulture
Veterinary Sciences *	2.304	Q1	• Veterinary Sciences
Universe	2.278	Q3	• Physics, Particles & Fields
			• Astronomy & Astrophysics
Mathematics	2.258	Q1	• Mathematics
Magnetochemistry	2.193	Q3	• Chemistry, Inorganic & Nuclear
			• Chemistry, Physical
			• Materials Science, Multidisciplinary
Current Issues in Molecular Biology	2.081	Q4	• Biochemistry & Molecular Biology
Actuators	1.994	Q3	• Instruments & Instrumentation
			• Engineering, Mechanical
Aerospace *	1.659	Q2	• Engineering, Aerospace

* Journals given their first Impact Factor in 2021

We are pleased to announce that, up to now, 116 distinguished scholars have joined the JCM Editorial Board in this quarter, including the well-known Prof. Dr. Aldo Pietro Maggioni from the ANMCO Research Center of the Heart Care Foundation, Prof. Dr. Paolo P. Prandoni from the "Arianna Anticoagulazione" Foundation, Dr. Stefan Evers from the University of Münster, Prof. Dr. Ben Willem Mol from Monash University, Prof. Dr. Tobias Welte from Medizinische Hochaschule Hannover, Prof. Dr. Fabiola Atzeni from the University of Messina, Prof. Dr. Gianluca Aimaretti from Università del Piemonte Orientale, Prof. Dr. Eva Compérat from L’Assistance Publique-Hôpitaux de Paris and various other prominent academics. 

You can access more information on our new members on the website: https://www.mdpi.com/journal/jcm/editors. 

Their trust in JCM is much appreciated, and we look forward to their contributions to the journal.

MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.

Selections

In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.

This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.

 

We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.

Special Issue Reprints

The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool  to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.

For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.

In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.

 

Why choose MDPI Books?

In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.

If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.

Contact: Laura Wagner, MDPI Books Manager (email)

In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.

MDPI has been a pioneer of Open Access publishing ever since the concept was first created.

In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.

Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.

Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.

MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.

At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.

As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.

We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.

The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.

We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.

The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.

Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)

We are pleased to announce that the first International Electronic Conference on Clinical Medicine (ECCM), chaired by Prof. Dr. Emmanuel Andrès, from the University Hospital of Strasbourg, France, and Prof. Dr. Michael G. Hennerici, from the University of Heidelberg, Germany, will be held on 15–30 September 2021 at Sciforum (https://sciforum.net/conference/ECCM).

The conference will cover all the multidisciplinary aspects of clinical medicine. The topics of interest include, but are not limited to, the following:

Cardiology

COVID-19

Gastroenterology and Hepatopancreatobiliary Medicine

Oncology

Infectious Diseases

Pulmonology

Hematology

Neurology and Stroke Neurology

Stomatology

Clinical Psychology

Psychiatry

Obstetrics and Gynecology

Endocrinology and Metabolism

Nephrology and Urology

Epidemiology and Public Health

Orthopedics

Dermatology

Ophthalmology

Otolaryngology

Nuclear Medicine and Radiology

Pharmacology

Anesthesiology

Emergency Medicine

The conference will be completely free of charge, both to attend and, for scholars, to upload and present their latest work on the conference platform. Accepted abstract submissions will be published in the proceedings of the conference, and authors are invited to develop their abstracts into full manuscripts, which will be considered for publication in JCM, with a 10% discount on the APC. JCM is an open access journal, published semimonthly by MDPI, in the field of clinical medicine. The journal is indexed in the Science Citation Index Expanded (SCIE IF = 3.303) and other databases. Full texts are archived in PubMed Central (PMC).

Important Dates

• Abstract Submission: 31 May 2021
• Acceptance Notification: 14 June 2021
• Full Paper Submission: 12 July 2021
• Conference Open: 15–30 September 2021

For more information on ECCM, please visit the conference website (https://sciforum.net/conference/ECCM) or contact us by email ([email protected]).

In November 2020, the Spanish Society of Hematology and Hemotherapy (SEHH) became affiliated with Hemato, JCM and Cells. As part of this collaboration, all members of the SEHH enjoy a discount on the article processing charge (APC) when submitting articles to the journals.

The SEHH is a scientific society purposed with the promotion, development and dissemination of research advances in two specialist areas, Hematology and Hemotherapy. In particular, the SEHH focuses on their medical, scientific, organizational, care, teaching and research aspects. Hematology, as a specialty, covers all aspects related to the physiology of the blood and hematopoietic organs, the diagnosis and treatment of benign and malignant diseases of the blood, the study of the hemostasis and coagulation system, and all aspects related to transfusion medicine, including hematopoietic stem cell transplantation. The professional role of the hematologist covers all aspects of the practice.

With 61 years of history, the SEHH is today an organization that contributes significantly to science. At present, it holds a community of almost 2800 professionals, of which many are internationally recognized figures, who continually contribute to making hematology, globally, one of the most prestigious fields of Spanish medicine. The society considers that, in order to achieve optimal patient care, it is essential to have access to medical advances, promote research and have well-trained and highly qualified specialists in the management of hematological diseases.

The SEHH is a professional organization whose functions and research are highly relevant to the scope of Hemato, JCM and Cells. We look forward to collaborating with the SEHH and to publishing state-of-the-art research from its members.

It is our pleasure to announce that seven JCM Editorial Board Members have been listed as 2020 Highly Cited Researchers by Clarivate. This corresponds to being in the top 1% of the most cited researchers for that publication year.

Prof. Dr. Robert C. Cantu

1. Department of Neurology, Boston University Alzheimer’s Disease and CTE Centers, Boston University School of Medicine, Boston, USA; 
2. Department of Neurosurgery, Boston University School of Medicine, Boston, USA； Concussion Legacy Foundation, Boston, MA, USA; 
3. Department of Neurosurgery, Emerson Hospital, Concord, USA
Interests: Neurosurgery; Spine Surgery; Sports Medicine; Concussion Care

Dr. Michael R. Hamblin

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA
Interests: photodynamic therapy (PDT); low-level light therapy (LLLT); wound healing and infectious disease; atherosclerotic vulnerable plaque; anti-tumor immunity; photochemical mechanisms

Prof. Dr. Hans-Peter Hartung

Department of Neurology, Medical Faculty, Heinrich-Heine-University, Moorenstrasse 5, 40225, Düsseldorf, Germany
Interests: immune mediated neurological disroders; multiple sclerosis; NMOSD; immune encephalitides; immune neuropathies; Guillan Barre syndrome and CIDP

Prof. Dr. Gregory Y. H. Lip

1. Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, United Kingdom
2. Distinguished Professor, Aalborg University, Denmark
Interests: atrial fibrillation; hypertension; thrombosis and anticoagulation

Prof. Dr. Russel J. Reiter

Department of Cellular & Structural Biology, The UT Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
Interests: melatonin; free radicals of disease processes and aging; oxygen derivatives

Prof. Fred Saad

Centre Hospitalier de Université de Montréal, Montreal, Canada
Interests: Prostate cancer; biomarkers; novel therapeutics; castration resistant prostate cancer; GU cancers; metastases prevention

Dr. Allan H. Young

Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Interests: Bipolar disorder; treatment resistant depression; cognition; translational

The 2020 Highly Cited Researchers list has been announced by Web of Science at: https://recognition.webofscience.com/awards/highly-cited/2020/.

MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.

The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.

MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.

Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.

The Coalition is committed to:

• eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
• creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
• promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
• raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
• supporting our members in achieving diversity and inclusion within their organizations.

At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.

The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.

The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:

1) Information is displayed in the left information bar.

2) In the main text, there is a blank column on the left.

3) Small tables/figures are aligned on the left, large tables/figures are centered.

We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.

Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.

Adams, Dave Agarwal, Ravi P. Ahn, Choon Ki Ahn, Myung-Ju Albrecht, Randy A. Andersson, Dan I. Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Artaxo, Paulo Balsamo, Gianpaolo Barba, Francisco J. Benediktsson, Jon Atli Benelli, Giovanni Bhatnagar, Amit Bialystok, Ellen Blaabjerg, Frede Blay, Jean-Yves Bogers, Marcel Bolton, Declan J. Boyer, Cyrille Brocca, Luca Bruix, Jordi Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cabrerizo-Lorite, Francisco Javier Cai, Jianchao Calhoun, Vince D. Cantu, Robert C. Cerqueira, Miguel Chang, Jo-Shu Chau, Kwok-wing Chemat, Farid Chen, Jianmin Chen, Jun Chen, Min Chen, Shaowei Chen, Wei Chen, Wei-Hsin Chen, Xiaofeng Chen, Yangkang Chen, Zhi-Gang Chiclana, Francisco Corella, Dolores Cortes, Javier Cortes, Jorge Cummings, Kenneth Michael Dai, Shifeng Decker, Eric A. DePinho, Ronald A. Dimopoulos, Meletios-Athanasios Dincer, Ibrahim Du, Yihong Dupont, Didier Edwards, David Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estruch, Ramón Fang, Chuanglin Fasano, Alessio Fernandez-Lafuente, Roberto Ferreira, Isabel Fortino, Giancarlo Galluzzi, Lorenzo Galvano, Fabio Gandomi, Amir H. Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Wei Garbe, Claus García, Hermenegildo Geschwind, Daniel H. Giampieri, Francesca Giralt, Sergio A. Glanz, Karen Goldewijk, Kees Klein Gössling, Stefan Govindan, Kannan Granato, Daniel Grosso, Giuseppe Grosso, Giuseppe Guerrero, Josep M. Haase, Dagmar Hagger, Martin S. Hamblin, Michael R. Han, Heesup Jankovic, Joseph Janotti, Anderson

Jiang, Hai-Long Kalaji, Hazem M. Kalantar-Zadeh, Kourosh Kaner, Richard B. Karimi, Hamid Reza Kataoka, Kazunori Keesstra, Saskia Kepp, Oliver Kerminen, Veli-Matti Keyzers, Robert A. Khademhosseini, Ali Khan, Nafees A. Kim, Ki-Hyun Klemeš, Jiří Jaromír Klenk, Hans-Peter Konopleva, Marina Y. Krammer, Florian Krebs, Frederik C. Kroemer, Guido Kudo, Masatoshi Kurths, Juergen Kurzrock, Razelle Kuznetsov, Nikolay V. Kyrpides, Nikos C. La Vecchia, Carlo Lai, Yuekun Lam, James Lancellotti, Patrizio Lee, Sangmoon Leung, Victor C. M. Li, Jinghong Li, Yurui Lindahl, José M. Merigó Lip, Gregory Y. H. Loh, Xian Jun Long, Hualou Lund, Henrik Luo, Jingshan Luque, Rafael Lyons, Timothy W. Ma, Jun Ma, Wen-Xiu Ma, Yanming Maeda, Keisuke Makarova, Kira Mantovani, Alberto Martín-Belloso, Olga Martinoia, Enrico Marzband, Mousa Masclaux-Daubresse, Celine Masson, Patrick Mateos, María Victoria Mathiesen, Brian Vad Matyjaszewski, Krzysztof McArthur, Grant A. McCauley, Darren Medlock, Jolyon M. Melero, Ignacio Mezzetti, Bruno Miroshnichenko, Andrey E. Moran, Daniel Mueller, Lukas A. Mueller-Roeber, Bernd Naushad, Mu Nemeroff, Charles B. Nieto, Juan J. O'Donnell, Colm Ogino, Shuji Olabi, Abdul-Ghani O'Regan, Donal Orsini, Nicola Oswald, Isabelle P. Ozcan, Aydogan Pahl-Wostl, Claudia Pang, Huan Payne, James E. Peng, Shushi Perc, Matjaz Perez-Alvarez, Jose Angel Piquero, Alex R. Ploss, Alexander Postolache, Mihai Pradhan, Biswajeet Prinsep, Michele R. Qian, Dong Qu, Xiaogang Reiter, Russel J. Riahi, Keywan Richter, Andreas Rignot, Eric Robert, Caroline Ros, Emilio Rosell, Rafael

Rosen, Marc A. Rossolini, Gian Maria Saad, Fred Saad, Walid Sadorsky, Perry Sakthivel, Rathinasamy Schwab, Matthias Scolyer, Richard A. Serra-Majem, Lluis Sethi, Gautam Seto, Karen C. Settele, Josef Seymour, John F. Shi, Peng Siano, Pierluigi Sillanpää, Mika Simal-Gandara, Jesus Smagghe, Guy Srivastava, Hari M. Stadler, Peter F. Sun, Fengchun Sunderland, Elsie M. Suzuki, Nobuhiro Svenning, Jens-Christian Tan, Weihong Teixeira, José António Thakur, Vijay Kumar Tong, Shilu Tornabene, Francesco Tsao, Rong Tukker, Arnold Turskis, Zenonas Uversky, Vladimir N. van Wesemael, Bas Van Zwieten, Lukas Vangronsveld, Jaco Varma, Rajender S. Varshney, Rajeev K. Vasquez, Juan C. Velicogna, Isabella Vieta, Eduard Wade, Timothy J. Wagner, Wolfgang Wamba, Samuel Fosso Wang, Chunsheng Wang, Guoxiu Wang, Joseph Wang, Qi Wang, Tao Wang, Yuan Wiens, John J. Wu, Hao Bin Wu, Hui Wu, Tom Wu, Zhongbiao Xia, Xinhui Xiao, Wenjiao Xin, Sen Xiong, Rui Xu, Bin Xu, Zeshui Yan, Huaicheng Yang, Bing Yang, Hongxing Yang, Jie Yang, Xiao-Jun Yin, Shen Ying, Guang-Guo Young, Allan H. Yu, Guihua Zarco-Tejada, Pablo J. Zavadskas, EdmundasKazimieras Zeadally, Sherali Zhang, Fan Zhang, Liangpei Zhang, Qichun Zhang, Xian-Ming Zhang, Yue-Jun Zhao, Guochun Zhao, Li-Dong Zhu, Zhe Zhuang, Xiaodong Zou, Quan

The full list of 2020 Highly Cited Researchers  can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/

--- Highly Cited Researchers (HCR) is a Clarivate product.

JCM is recruiting Editorial Board Members for the following sections:

https://www.mdpi.com/journal/jcm/sections.

The main responsibilities of Editorial Board Members are as follows:

1) Making decisions on whether a manuscript can be accepted based on the reports we collect;

2) Reviewing a small number of papers each year;

3) Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;

4) Promoting JCM and increasing its visibility at related academic conferences.

Journal of Clinical Medicine (ISSN 2077-0383) is an international scientific open-access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients, and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals. It is abstracted and indexed in the Science Citation Index Expanded in Web of Science and other databases, with citations available in PubMed, and is full-text archived in PubMed Central. The 2019 IF for JCM was 3.303.

This position is open to experts in clinical medicine. To apply for this position (in one of our Sections), recommend potential candidates, or request further information, please contact the JCM Editorial Office ([email protected]) or Lily Pei ([email protected]).

 

Preterm birth (PTB) remains one of the biggest challenges in contemporary obstetrics as it is associated with an increased risk of mortality as well as short- and long-term morbidity of the offspring. Many risk factors for PTB have been identified, including multiple gestation, placental insufficiency, cervical pathology and uterine factors, among others. As a result, many women are currently classified as at high risk for PTB. Accurate prediction of PTB is crucial as it can assist in selecting the optimal prevention measurements and counseling regarding the suitable antepartum follow up and the need for potential transfer to the appropriate facility in case of very high risk of PTB.

With a distinguished panel of leaders in this field, Professors Liran Hiersch, John Kingdom, Nathan Fox, Tal Biron-Shental and Ido Solt, this webinar will address aspects and perspectives on the prediction of PTB in various clinical scenarios.

Date: 6th December 2020 | 3:00 p.m. CET | 9:00 a.m. EST

Webinar ID: 862 1088 3441

Register for Free Here: https://clincialmed-4.sciforum.net/

Chair:

	His main fields of interest include twin pregnancies, fetal growth and preterm birth.
Dr. Liran Hiersch

Speakers:

	Presentation: Placenta Growth Factor: predicting placenta-mediated preterm delivery
Dr. John Kingdom
	Presentation: Prediction and Prevention of Preterm Birth in Twins
Dr. Nathan Fox
	Presentation: The correlation between telomere homeostasis and gestational length
Prof. Tal Biron-Shental
	Presentation: Is the vaginal microbiome a predictor of preterm birth?
Dr. Ido Solt

For any questions about the webinar, please contact us at [email protected].

MDPI acquired Current Oncology (ISSN 1718-7729) in October 2020 from Multimed Publications Inc., who launched the title in 1994, as Canada’s first peer-reviewed journal in oncology.

Current Oncology features papers in all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. It continues to be a trusted source for all members of the oncology community in Canada and abroad.

Coverage in indexing services includes MEDLINE (PubMed/National Library of Medicine), the Science Citation Index Expanded (Web of Science), Journal Citation Reports, Scopus (Elsevier), EMBASE (Elsevier), and more. Current Oncology's 2019 Impact Factor is 2.257, ranked 185/244 in the 'Oncology' category.

Previously published six times annually, normally with one or two additional supplements, MDPI will continue the schedule of bimonthly publications. The current volume of Current Oncology (v. 27) will be concluded at the end of 2020, at which point MDPI will take over publication of the journal, starting with Volume 28, at the beginning of 2021.

The goal is to greatly expand the journal's global reach, alongside MDPI's flagship Cancers journal, in order to become one of the world’s leading oncology journals.

Website: https://www.mdpi.com/journal/curroncol

Contact: Danica Jevtic, Marko Ristic
Current Oncology Editorial Office

The JCM Outstanding Research Award was initiated to recognize outstanding research by authors of the journal that has had a significant international impact. The novelty and significance of research works were assessed by the JCM Editorial Board and reviewers along with consideration of the citations.

We are very pleased to announce that Dr. Robin Nicholas Thompson will be granted the JCM 2020 Outstanding Research Award for his contribution of using mathematical models to represent the epidemiological or evolutionary behavior of infectious disease outbreaks. The main aims are not only to generate forecasts of specific outbreaks but also to understand how diseases spread such that forecasts can be made, and control interventions can be planned with more precision.

His paper “Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations” published in February 2020 (https://www.mdpi.com/2077-0383/9/2/498) was recognized as recommended reading by the World Health Organization.

Please join us in congratulating Dr. Thompson on receiving this award.

Dry Eye Disease (DED) has gained recognition as a public health problem given its prevalence, morbidity, and cost implications. DED can have a variety of symptoms including blurred vision and ocular pain (dryness, burning aching) and a variety of signs including decreased tear production, corneal epithelial disruption, and rapid tear evaporation. However, it is well known that there is often a discrepancy between symptoms and signs of disease.

Date: 1.30pm (CET) | 06.30am (CDT)

Duration: Maximum 2 hours

Webinar ID: 961 1378 0758

Register for Free Here: https://sciforum.net/conference/JCM3

Chair:

	Presentation: DED from the outside- a discussion on the interaction between environmental exposures and the ocular surface, and their manifestation as DED.
Associate Professor Anat Galor Guest Editor of “Dry Eye Syndrome: New Insights on Epidemiology and Management”

Speakers:

	Presentation: DED from the inside- a discussion on systemic co-morbidities that may associated and drive disease.
Professor Stephen C. Pflugfelder
	Presentation: DED and the local neighborhood- a discussion on effects of the periocular skin and eyelids on the ocular surface and DED.
Associate Professor Jennifer Craig

For any questions about the webinar, please email [email protected].

Preterm delivery (PTD; <37 weeks' gestation) complicates 5-13% of deliveries worldwide depending on the geographical and demographical characteristics of the population tested. Based on data from 184 countries, the global average preterm birth rate in 2010 was 11.1% giving a worldwide 14.9 million. It is the leading cause of perinatal morbidity and mortality as well as maternal morbidity. With a distinguished panel of Professors Eyal Sheiner, Gian Carlo Di Renzo, Shali Mazaki-Tovi and Nir Melamed, this webinar will address and share new perspectives on the prevention and monitoring of Preterm Delivery.

Date: 24 September 2020 | 1 pm (CEST) | 7 am (EDT) | 7 am (CST Asia)

Duration: Maximum 2 hours

Webinar ID: 856 8826 9334

Register for Free Here: https://sciforum.net/conference/ClinicalMed-2

Chair:

	Presentation: Preterm delivery and other “placental” complications, and long-term maternal morbidity.
Professor Dr. Eyal Sheiner Guest Editor of “Advances in Preterm Delivery”

Speakers:

	Presentation: Prevention of preterm birth: The evidence
Prof. Dr. Gian Carlo Di Renzo
	Presentation: Bad rest or bed rest: efficacy and safety of decreased physical activity for the prevention of preterm birth.
Prof. Dr. Shali Mazaki-Tovi
	Presentation: Is there a role for serial monitoring of cervical length in twin pregnancies?
Prof. Dr. Nir Melamed

For any questions about the webinar, please send an email to [email protected].

MDPI will be attending the conference Neuroscience 2020, which will be hosted in Washington, USA, 24–28 October 2020.

SfN’s 50th annual meeting is the premier venue for the presentation of emerging science in the field of neurosciences, where one can learn from experts, forge collaborations with peers, explore new tools and technologies, and advance their career.

The following MDPI journals will be represented:

• Brain Sciences (leading journal)
• JCM
• Medicina
• Genes
• Children
• Cancers
• Behavioral Sciences
• Cells
• IJERPH
• Disease
• Biomedicines
• JPM
• Pathogens
• Healthcare
• IJMS
• Psych
• Pharmaceuticals
• Clocks&Sleep
• Jounal of Intelligence
• Pharmaceutics

If you are attending this conference, please feel free to stop by our booth (Booth #208). Our delegates look forward to meeting you in person, to answer any questions you may have. For more information about the conference, please visit:

https://www.sfn.org/meetings/neuroscience-2020

It is our pleasure to announce that five JCM Editorial Board Members have been listed as Highly Cited Researchers:

Prof. Fred Saad

Centre Hospitalier de Université de Montréal, Montreal, Canada
Interests: prostate cancer; biomarkers; novel therapeutics; castration resistant prostate cancer; GU cancers; metastases prevention

Prof. Dr. Gregory Y. H. Lip

1. Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, United Kingdom
2. Distinguished Professor, Aalborg University, Denmark
Interests: atrial fibrillation; hypertension; thrombosis and anticoagulation

Prof. Dr. Laxmaiah Manchikanti

Pain Management Center of Paducah Associate Clinical, Anesthesiology and Perioperative Medicine, University of Louisville, 2831 Lone Oak Road, Paducah, KY 42003, USA
Interests: back pain; low back pain; opioids; spinal pain; chronic pain; interventional pain management

Dr. Michael R. Hamblin

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA
Interests: photodynamic therapy (PDT); low-level light therapy (LLLT); wound healing and infectious disease; atherosclerotic vulnerable plaque; anti-tumor immunity; photochemical mechanisms

Prof. Dr. Russel J. Reiter

Department of Cellular &amp; Structural Biology, The UT Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
Interests: melatonin; free radicals of disease processes and aging; oxygen derivatives

The 2019 Highly Cited Researchers list has been announced by Web of Science at:

https://recognition.webofsciencegroup.com/awards/highly-cited/2019/

We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.

All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.

Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.

About Jisc

Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection.  Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.

For more information, contact [email protected]

About MDPI

MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).

For any questions about this agreement, please contact the MDPI IOAP team at [email protected].

The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.

• Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
• 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
• Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).
  
  

First Impact Factors

Journal	Impact Factor	Rank	Category	Details
Actuators	1.957	31/64 (Q2)	• Instruments & Instrumentation	Link
Agriculture	2.072	25/91 (Q2)	• Agronomy	Link
Biology	3.796	19/93 (Q1)	• Biology	Link
Biomedicines	4.717	30/138 (Q1) 36/270 (Q1)	• Medicine, Research & Experimental • Pharmacology & Pharmacy	Link
Biosensors	3.240	24/86 (Q2)	• Chemistry, Analytical	Link
Chemosensors	3.108	16/64 (Q1) 27/86 (Q2) 13/27 (Q2)	• Instruments & Instrumentation • Chemistry, Analytical • Electrochemistry	Link
Children	2.078	50/128 (Q2)	• Pediatrics	Link
Healthcare	1.916	62/102 (Q3) 45/87 (Q3)	• Health Care Sciences & Services (SCIE) • Health Policy & Services (SSCI)	Link
Journal of Fungi	4.621	5/29 (Q1) 31/135 (Q1)	• Mycology • Microbiology	Link
Journal of Personalized Medicine	4.433	24/165 (Q1) 10/102 (Q1)	• Medicine, General & Internal • Health Care Sciences & Services	Link
Land	2.429	58/123 (Q2)	• Environmental Studies (SSCI)	Link
Life	2.991	26/93 (Q2) 109/267 (Q2)	• Biology • Microbiology	Link
Magnetochemistry	1.947	22/45 (Q2) 109/159 (Q3) 201/314 (Q3)	• Chemistry, Inorganic & Nuclear • Chemistry, Physical • Materials Science, Multidisciplinary	Link
Membranes	3.094	53/143 (Q2) 129/314 (Q2) 23/89 (Q2)	• Engineering, Chemical • Materials Science, Multidisciplinary • Polymer Science	Link
Pharmaceuticals	4.286	49/270 (Q1)	• Pharmacology & Pharmacy	Link
Photonics	2.140	48/97 (Q2)	• Optics	Link
Separations	1.900	53/86 (Q3)	• Chemistry, Analytical	Link
Toxics	3.271	32/92 (Q2) 92/265 (Q2)	• Toxicology • Environmental Sciences	Link

Updated Impact Factors

Journal	Impact Factor	Rank	Category	Details
Agronomy	2.603	18/91 (Q1) 65/234 (Q2)	• Agronomy • Plant Sciences	Link
Animals	2.323	10/63 (Q1) 14/142 (Q1)	• Agriculture, Dairy & Animal Science • Veterinary Sciences	Link
Antibiotics	3.893	23/93 (Q1) 64/270 (Q1)	• Infectious Diseases • Pharmacology & Pharmacy	Link
Antioxidants	5.014	10/139 (Q1) 56/297 (Q1) 7/61 (Q1)	• Food Science & Technology • Biochemistry & Molecular Biology • Chemistry, Medicinal	Link
Applied Sciences	2.474	161/314 (Q3) 32/91 (Q2) 88/177 (Q2) 62/154 (Q2)	• Materials Science, Multidisciplinary • Engineering, Multidisciplinary • Chemistry, Multidisciplinary • Physics, Applied	Link
Atmosphere	2.397	48/93 (Q3)	• Meteorology & Atmospheric Sciences	Link
Biomolecules	4.082	98/297 (Q2)	• Biochemistry & Molecular Biology	Link
Brain Sciences	3.332	113/271 (Q2)	• Neurosciences	Link
Cancers	6.126	37/244 (Q1)	• Oncology	Link
Catalysts	3.520	65/159 (Q2)	• Chemistry, Physical	Link
Cells	4.366	70/195 (Q2)	• Cell Biology	Link
Coatings	2.436	10/21 (Q2)	• Materials Science, Coatings & Films	Link
Crystals	2.404	10/26 (Q2) 165/314 (Q3)	• Crystallography • Materials Science, Multidisciplinary	Link
Diagnostics	3.110	39/165 (Q1)	• Medicine, General & Internal	Link
Diversity	1.402	119/168 (Q3)	• Ecology	Link
Electronics	2.412	125/266 (Q2)	• Engineering, Electrical & Electronic	Link
Energies	2.702	63/112 (Q3)	• Energy & Fuels	Link
Entropy	2.494	33/85 (Q2)	• Physics, Multidisciplinary	Link
Foods	4.092	27/139 (Q1)	• Food Science & Technology	Link
Forests	2.221	17/68 (Q1)	• Forestry	Link
Genes	3.759	53/177 (Q2)	• Genetics & Heredity	Link
Insects	2.220	18/101 (Q1)	• Entomology	Link
International Journal of Environmental Research and Public Health (IJERPH)	2.849	58/193 (Q2) 32/170 (Q1) 105/265 (Q2)	• Public, Environmental & Occupational Health (SCIE) • Public, Environmental & Occupational Health (SSCI) • Environmental Sciences (SCIE)	Link
International Journal of Molecular Sciences (IJMS)	4.556	74/297 (Q1) 48/177 (Q2)	• Biochemistry & Molecular Biology • Chemistry, Multidisciplinary	Link
ISPRS International Journal of Geo-Information (IJGI)	2.239	31/50 (Q3) 18/30 (Q3)	• Geography, Physical • Remote Sensing	Link
Journal of Clinical Medicine	3.303	36/165 (Q1)	• Medicine, General & Internal	Link
Journal of Marine Science and Engineering	2.033	31/66 (Q2)	• Oceanography	Link
Marine Drugs	4.073	16/61 (Q2)	• Chemistry, Medicinal	Link
Materials	3.057	132/314 (Q2)	• Materials Science, Multidisciplinary	Link
Mathematics	1.747	28/324 (Q1)	• Mathematics	Link
Medicina	1.205	107/165 (Q3)	• Medicine, General & Internal	Link
Metabolites	4.097	95/297 (Q2)	• Biochemistry & Molecular Biology	Link
Metals	2.117	18/79 (Q1) 185/314 (Q3)	• Metallurgy & Metallurgical Engineering • Materials Science, Multidisciplinary	Link
Micromachines	2.523	56/92 (Q3) 23/64 (Q2)	• Nanoscience & Nanotechnology • Instruments & Instrumentation	Link
Microorganisms	4.152	37/135 (Q2)	• Microbiology	Link
Minerals	2.380	6/21 (Q2) 11/30 (Q2)	• Mining & Mineral Processing • Mineralogy	Link
Molecules	3.267	70/177 (Q2) 141/297 (Q2)	• Chemistry, Multidisciplinary • Biochemistry & Molecular Biology	Link
Nanomaterials	4.324	89/314 (Q2) 42/103 (Q2)	• Materials Science, Multidisciplinary • Nanoscience & Nanotechnology	Link
Nutrients	4.546	17/89 (Q1)	• Nutrition & Dietetics	Link
Pathogens	3.018	65/135 (Q2)	• Microbiology	Link
Pharmaceutics	4.421	44/270 (Q1)	• Pharmacology & Pharmacy	Link
Plants	2.762	58/234 (Q1)	• Plant Sciences	Link
Polymers	3.426	16/89 (Q1)	• Polymer Science	Link
Processes	2.753	59/143 (Q2)	• Engineering, Chemical	Link
Remote Sensing	4.509	9/30 (Q2)	• Remote Sensing	Link
Sensors	3.275	22/86 (Q2) 77/266 (Q2) 15/64 (Q1)	• Chemistry, Analytical • Engineering, Electrical & Electronic • Instruments & Instrumentation	Link
Sustainability	2.576	120/265 (Q2) 26/41 (Q3) 53/123 (Q2) 6/8 (Q3)	• Environmental Sciences (SCIE) • Green & Sustainable Science & Technology (SCIE) • Environmental Studies (SSCI) • Green & Sustainable Science & Technology (SSCI)	Link
Symmetry	2.645	29/71 (Q2)	• Multidisciplinary Sciences	Link
Toxins	3.531	21/92 (Q1) 34/139 (Q1)	• Toxicology • Food Science & Technology	Link
Universe	1.752	18/29 (Q3) 42/68 (Q3)	• Physics, Particles & Fields • Astronomy & Astrophysics	Link
Vaccines	4.086	57/158 (Q2) 50/138 (Q2)	• Immunology • Medicine, Research & Experimental	Link
Viruses	3.816	12/37 (Q2)	• Virology	Link
Water	2.544	31/94 (Q2)	• Water Resources	Link

Source: Clarivate 2020, InCites Journal Citation Reports®.

The Journal of Clinical Medicine (ISSN 2077-0383), an MDPI open access journal on health care, clinical practices, and general medical research, has passed another milestone by publishing its 5000th article since its inception in 2012.

JCM is now covered in the Science Citation Index Expanded in Web of Science and received an impact factor of 5.688 in 2018, which corresponds to a ranking of 15/160 (Q1) under the category ‘Medicine, General & Internal’.

JCM publishes original research covering the following non-exhaustive list of topical areas: Anesthesiology, Cardiology, Clinical Cytology, Clinical Neurology, Clinical Psychology, Dermatology, Emergency Medicine, Endocrinology & Metabolism, Epidemiology & Public Health, Gastroenterology & Hepatopancreatobiliary Medicine, Hematology, Immunology, Infectious Diseases, Molecular Diagnostics, Nuclear Medicine & Radiology, Nephrology & Urology, Obstetrics & Gynecology, Oncology, Ophthalmology, Orthopedics, Otolaryngology, Pharmacology, Psychiatry, Pulmonology, Vascular Medicine, Stomatology.

Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.

The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.

COVID-19 Academic Resources Center contains a variety of information related to COVID-19 available from MDPI, including journal articles, special issues, and preprints, among others.

For more information, please visit: https://www.mdpi.com/covid-19

MDPI will be attending the European Society of Cardiology Congress 2020(ESC Congress 2020) in Amsterdam, The Netherlands, 29 Aug–2 Sep 2020.

ESC Congress 2020 will build on the solid foundations of a congress which attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.

The following MDPI journals will be represented:

• JCM
• Medicina
• JCDD
• Medicines
• JPM
• Healthcare

If you are also attending this conference, please feel free to stop by our booth (Booth N600). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit here.

As a leading Open Access publisher, MDPI is committed to fostering open scientific exchange in all forms across all disciplines. Due to the outbreak of COVID-19, many researchers have to stay at home and many academic conferences have been cancelled or postponed. In light of these changes, MDPI has adopted numerous initiatives that may help accelerate scientific exchange and provide support to the academics during this period.

Scholarly Community—Encyclopedia

Encyclopedia is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

Comprehensive and Free Literature Database—Scilit

Scilit is a comprehensive, free database for scientists that uses a new method to collate data and index scientific material. Our crawlers extract the latest data from CrossRef and PubMed on a daily basis. This means that newly published articles are immediately added to Scilit.

Display Academic Achievements—SciProfiles

SciProfiles is an innovative social network for researchers and scholars that is developed by MDPI. In line with our broad mission, the purpose of SciProfiles is to accelerate discovery and innovation by facilitating immediate access to research results and providing opportunities for academic networking.

Organize and Participate in Conferences Online—Sciforum

Sciforum is an event planning platform that supports open science by offering the opportunity to host and participate in academic conferences. It provides an environment for scholarly exchange, discussion of topics of current interest, building of networks, and establishing collaborations.

Post Early Versions of Research Outputs—Preprints

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. We post original research articles and comprehensive reviews, and papers can be updated by authors at any time. Content on Preprints is not peer-reviewed, and feedback can be received from readers.

***

MDPI remains committed to open science and open data and has signed a statement, along with more than thirty scholarly publishers, showing our intention to facilitate sharing of new research findings as early on as possible. The initiative sees publishers collectively removing barriers to new research, in the face of a global healthcare crisis.

The world is currently suffering from a global pandemic of the corona virus COVID-19. MDPI expresses its sympathies for all of those affected by the virus and stands in solidarity with medical staff and researchers treating patients and searching for scientific solutions.

MDPI has previously published papers covering corona viruses in addition to new papers on the current outbreak, see all papers here. In particular, Viruses has published a number of Special Issues and papers on the topic (see here, here, and here) as well as a forthcoming Special Issue.

Alongside journal articles, MDPI has been a strong supporter of preprints, which are increasingly being used to rapidly disseminate the latest research, and we run the preprint server Preprints.org. Our database of research articles, Scilit, is free to use and covers all publishers including preprint servers. New papers are often in search results within hours of publication and users can set up alerts for new papers.

Our main priority during this period has been the health and safety of staff, and we continue to allow staff to work at home and closely monitor the situation in all locations in which we work. Despite the restrictions, we continue to provide a full publication service and, by close collaboration with our editorial boards and making use our in-house teams, ensure that there are no unnecessary delays in publishing vital research. Fast and open publication has always been at the core of MDPI values and is now more important than ever.

We hope that a solution to the current situation will emerge soon. In the meantime, we will do our best to continue communicating vital research in all fields.

MDPI has endorsed Open Pharma’s Position Statement in support of open access publishing with the aim of advancing medical science and ultimately, improving patient care. Open pharma is a group of research funders, healthcare professionals, publishers, academics, and other healthcare stakeholders.

Since its inception in 1996, MDPI’s efforts have aligned with Open Pharma’s vision of more effective and transparent publishing, collaborating internationally with experts to deliver peer-reviewed online research journals to the scientific community and the general public. MDPI publishes 56 journals in the field of Medicine and Pharmacology and is planning to hold the World Pharma Forum in Basel in 2021.

Published under a Creative Commons License, MDPI’s articles can be freely shared and their content re-used, upon proper attribution. In support of the statement, MDPI will continue to uphold its open access policy and provide fast editorial services to ensure that new medical evidence can be read by everyone, without paywall restrictions.

The advantages of the open access model of scientific publishing are being increasingly recognized in the scientific community. It allows new scientific evidence to be accessed from the moment of publication for free by anyone around the globe, boosting the impact of new research. In response, many funders, libraries and universities have been adopting new principles to accelerate the transition to open access.

Recently, “transformative agreements” have been negotiated between traditional publishers and various institutions. While increasing the number of open access papers, these agreements lack binding commitments to a full transition to open access, their conditions vary across different regions, and access is still limited for many users.

MDPI is a co-signatory of the recent position statement raising concerns about potential downsides of transformative agreements and how they may delay a full transition to open access. The statement highlights that these models “risk perpetuating current limitations on access, transparency and market competitiveness, while simultaneously facilitating excessive charges on the public purse”.

As a pioneering open access journal publisher, MDPI is the first to promote the importance of science being made available to everyone. Our peer-reviewed journals, covering diverse academic disciplines, are fully accessible to the public free of charge under a Creative Commons Attribution License (CC BY). This is why, along with other open access publishers, MDPI is a proud signatory of the position paper and is committed to contributing to the replacement of weak transitional agreements with “agreements with publishers that are already fully committed to open science and who offer full, immediate and transparent Open Access”.

Read the position paper here

We are pleased to announce that Encyclopedia will be awarding five Outstanding Contributor Awards for researchers in 2020. The nominations and applications will be assessed by an Evaluation Committee consisting of senior scholars from the Encyclopedia Editorial Board.

Prize for Winners

1. An official certificate;
2. A cash award of 500 CHF or an MDPI discount voucher of 800 CHF.

Application Deadline

31 December, 2020 (Please send your application email with a list of all entries you contributed to our office before the deadline: [email protected])

Candidate Requirements

1. Have a Ph.D. degree;
2. Have more than three qualified entries published in Encyclopedia in 2020.

Evaluation Standards

1. Number of entries published in Encyclopedia in 2020;
2. Quality of entries online (including length, figure quality, and novelty);
3. Impact of entries (including the number of likes, discussion contents, views, and downloads).

If you are a researcher and have not yet contribute entries to Encyclopedia, please do not miss this chance to highlight your research results.

We are pleased to announce that our journals Animals, Cancers and Journal of Clinial Medicine (JCM) are starting to accept submissions of Registered Reports, to be considered for publication in one of these journals.

Registered Reports are scientific articles which are peer-reviewed before the research is performed and the data are collected. The ideas that meet high scientific standards, such as rigor, soundness, significant importance and implications for the science community, are then provisionally accepted for publication before data collection starts. This format helps to considerably reduce publication bias and to avoid researchers having to invest much time and effort into questionable research studies, while allowing enough flexibility to perform unregistered experiments and report serendipitous findings.

The detailed guidelines for authors to prepare the manuscript can be accessed on the three journals’ instructions website, i.e., Animals, Cancers, Journal of Clinial Medicine. The guidelines for reviewers can be accessed online at Guidelines for Reviewers for Registered Reports Papers.

Please feel free to contact the respective journal editorial offices for related questions (Animals office; Cancers office; JCM office).

MDPI will be attending the American Thoracic Society (ATS) 2020 Congress in Philadelphia, PA, USA, 15–20 May 2020.

The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.

This international conference is also multidisciplinary. Clinicians and researchers in many other fields attend the conference, thereby enriching conversations that lead to insights that ultimately improve patient care.

The following MDPI journals will be represented:

• JCM
• IJERPH
• Medicina
• Cancers
• Children
• Brain Sciences
• Medicines
• JPM
• Healthcare

If you are also attending this conference, please feel free to stop by our booth (Booth 1101). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://conference.thoracic.org.

MDPI will be attending Precision Medicine World Conference 2020 in Silicon Valley, CA, USA, 21-24 January, 2020.

PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine.

The following MDPI journals will be represented:

• Journal of Personalized Medicine
• Journal of Clinical Medicine
• Medicial Sciences
• Cancers
• Healthcare
• Medicines
• Genes
• Diagnostics

If you are also attending this conference, please feel free to stop by our booth (Booth C1823). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.pmwcintl.com/

MDPI is pleased to announce the release of SciProfiles, its social network platform for researchers and scholars.

The purpose of SciProfiles is aligned with MDPI’s broad mission to accelerate discovery and innovation by facilitating immediate access to research results and to serve scholars and communities by providing opportunities for academic networking.

SciProfiles also ambitions to serve as a sustainable, transparent and community-driven research evaluation system aligned with the DORA principles (https://sfdora.org/). Through their scientific profiles, academics can highlight their contribution to research communities, and measure their impact on their field, beyond publication numbers and impact factors. SciProfiles is currently a beta version and will enrich to give researchers the possibility to highlight all of their contributions to science and their scientific communities as authors, reviewers, editors, conference organizers, conference panelists, conference keynote speakers, or even as lecturers or student mentors at their University.

The classic components of popular community social networks, including follower/following, classical metrics, endorsements and recommendations (https://www.mdpi.com/about/announcements/1690), comments (https://www.mdpi.com/about/announcements/1397) are or will be very soon highlighted in SciProfiles as open science contributions.

To help increase the impact and visibility of articles and their authors to an appropriate audience, the platform offers a NewsFeed that includes recommendations of relevant content based on interests, publication history, saved searches or colleagues’ recommendations.

SciProfiles’ avatars are now being integrated on several MDPI platforms, meaning that you will directly access researchers’ profiles from any of the MDPI platforms:

MDPI's journal publishing website: www.mdpi.com
MDPI's conference hosting and management website: www.sciforum.net
MDPI's pre-print website : www.preprints.org
MDPI's knowledge sharing website : www.encyclopedia.pub
MDPI's books store: www.mdpi.com/books
MDPI's literature database : www.scilit.net

SciProfiles aims to serve scientific communities at large. It can be embedded into third-party websites and also welcomes integration of data from third-parties.

Dr. Shu-Kun Lin: https://sciprofiles.com/profile/2
Dr. Franck Vazquez: https://sciprofiles.com/profile/FranckVazquez
Dr. Martyn Rittman: https://sciprofiles.com/profile/martynrittman

We are delighted to announce the winners of the 2019 MDPI Writing Prize. Entrants were asked to write on the theme "Judging research: How should research and researchers be evaluated and rewarded?" We received a large number of excellent essays from PhD students and postdocs, and the process of shortlisting and choosing winners was not an easy one. The winners demonstrated excellent writing skills alongside interesting and thought-provoking ideas.

As last year, we will begin the process of collating all entries into a book that will be available in open access format. Alongside promoting good writing skills, we see the prize as a way to promote the voices of early career researchers within broader debates and policy discussions.

Congratulations to all of the participants and especially the winners. The winners are:

1st Prize (500 CHF):
Albin Nilsson (National Centre for Nuclear Research, Warsaw, Poland)
[Read here]

2nd Prize (250 CHF):
Qi Zhang (Shandong University, Jinan, China)
[Read here]
Igor Ogashawara (Indiana University, Indianapolis, US)
[Read here]

3rd Prize (100 CHF):
Margaret Sivapragasam (Universiti Teknologi Petronas, Perak, Malaysia)
[Read here]
Arvind Sharma (The University of Queensland, Gatton, Australia)
[Read here]
Jose Flores-Guerrero (University Medical Center Groningen, Groningen, The Netherlands)
[Read here]

The MDPI Writing Prize is an annual award supported by MDPI Author Services, which provides services including language editing, reformatting, plagiarism checks, and image editing.

MDPI is pleased to announce the release of a new functionality giving the possibility for researchers and scholars to endorse, and formally recommend articles to their colleagues.

MDPI was an early signatory of the San Francisco Declaration on Research Assessment (https://sfdora.org/read/) which calls for improvement in how quality and impact of scholarly research outputs are evaluated, especially in moving beyond journal-based citation metrics (journal Impact Factor, Scopus Citescore, etc.).

MDPI supports the establishment of article-level impact metrics, including citations, views, downloads, and Altmetric scores. These measures serve as an impact indicator for research articles on a case–by-case basis, assessing paper on its own merit. However, these metrics are also subjective and can give a biased picture of the article impact: they do not directly reflect the quality or the intrinsic scientific value of the article.

In our view, community engagement with publications based on community-driven metrics can help to overcome this limitation. We have therefore launched an option for scholars to endorse articles, indicating their own assessment of its content and making a recommendation to their community. This follows our implementation of the open source Hypothesis commenting tool, which has been available for all articles published by MDPI for over a year (https://www.mdpi.com/about/announcements/1397). Both endorsement and commenting are available for all previously published and forthcoming MDPI articles.

In addition to potentially serving as a sustainable solution to article assessment, endorsements will help scientific communities to identify the most relevant articles, independently of the journal in which it was published.

The code for the endorsing functionality, which relies on DOIs and ORCIDs, will be made available on GitHub with an open source license.

Dr. Shu-Kun Lin, President and Founder
Dr. Franck Vazquez, Chief Scientific Officer
Dr. Martyn Rittman, Publishing Director

Encyclopedia is pleased to announce that certain well-prepared entries are eligible for a 100 CHF voucher, which can be used for paper publication in any journals in MDPI. We believe that your contribution would be a great help in keeping up with scientific developments. Do not miss the chance to publish with us. Please clink here to find the detailed guideline.

Encyclopedia is a free online reference created and curated by active scholars. It aims to highlight the latest research results as well as provide a comprehensive record of scientific development. If you have any suggestions or questions, please feel free to contact us via [email protected].

We are pleased to announce that Preprints has passed the milestone of 10,000 posted preprints. We are delighted to have reached this after just over three years of operation. Our congratulations and thanks go to our authors and advisory board who have supported growth of the platform and been crucial to its operation.

You can find further details at https://www.preprints.org/announcement/show/37.

Last week, the DeepGreen initiative in Germany started into an advanced test phase with the publishing partners S. Karger AG, SAGE Publishing, MDPI, Frontiers and De Gruyter, as well as 27 universities from all over Germany, from Hamburg University of Applied Sciences to University of Konstanz.

DeepGreen aims at lowering the barriers for open access publishing by automatically delivering metadata and full text publications from participating publishers to authorized repositories at German universities.

In preparation for a later live operation, the advanced test phase serves to gain experience with extensive data deliveries from publishers and also handling different repository software (including OPUS4, DSpace, EPrints, MyCoRe). DeepGreen thereby acts as a sophisticated platform, receiving articles published by authors affiliated with German universities and depositing these articles to respective university repositories, based on the affiliation metadata. For more information about DeepGreen: https://deepgreen.kobv.de

Karger AG has been a close cooperation partner of the DeepGreen consortium since 2016. S. Karger has more than 80 subscription-based and around 20 open access journals covering a wide spectrum in health science. DeepGreen will assign S. Karger articles to authorized institutions on the legal basis of German alliance and national licenses.

SAGE Publishing  was founded by Sara Miller McCune in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE publishes more than 1,000 journals and over 600 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. SAGE Publishing has been a close cooperation partner of DeepGreen since 2016.

MDPI  is a scientific open access publisher and has been a partner of DeepGreen since 2017. MDPI comprises 205 peer-reviewed journals of various disciplines. All articles are published under a CC-BY license and are freely available without embargo period.

Frontiers  is a scientific open access publisher with 61 journals of over 600 academic disciplines. All articles are peer-reviewed and published freely available under CC-BY license.

De Gruyter  is an academic publisher with more than 700 subscription-based and open access journals of 29 disciplines. Articles provided by De Gruyter will be assigned to institutions with German alliance and national licenses.

There is promising communication with other publishers.

DeepGreen is funded by the German Research Foundation (DFG) and the consortium comprises six institutions: the Cooperative Library Network Berlin-Brandenburg, Bavarian State Library, Bavarian Library Network, University Library of the Technische Universität Berlin, University Library of Erlangen-Nuremberg and the Helmholtz Open Science Coordination Office at the GFZ German Research Centre for Geosciences.

If you would like to know in more detail which institutions take part in the advanced test phase of DeepGreen, you can find more information here.

We will be attending the 2019 APHA Annual Meeting and Expo in Philadelphia, PA, USA from 2–6 November 2019. APHA's Annual Meeting and Expo is the largest and most influential annual gathering of public health professionals. Nearly 13,000 attendees join the conference each year to present, learn, and find inspiration. This year, the theme of the conference is “Creating the Healthiest Nation: For science. For action. For health”. Representatives of the following open access journals will attend:

IJERPH

Cancers

JCM

Healthcare

Vaccines

Microorganisms

Toxics

Sports

JPM

If you are also attending this conference, please feel free to stop by our booth (Booth #1144). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit https://www.apha.org/events-and-meetings/annual.

The University of Basel and the MDPI Sustainability Foundation are organizing the First Basel Sustainable Publishing Forum on 9th September 2019.

The aim of this event is to provide background and perspectives on Plan S to Learned Societies, which have to make well-informed decisions to transition their journals to Open Access (OA).

The BSPF will bring together several representatives of Learned societies, Plan S architects as well as representatives from various publishers and publishing platforms. After getting the big picture from cOAlition S, panel discussions will allow to better understand the diverse challenges that Learned societies are facing to transition their journals to OA as well as to identify sustainable, implementable and scalable solutions for successful Open Access transition.

For program details and registration, please follow the link below:
https://sciforum.net/conference/SustainableSolutionsToOpenAccess

We are pleased to inform that Journal of Clinical Medicine received an updated Journal Impact Factor of 5.688 in the recent release of the Journal Citation Reports®. Journal of Clinical Medicine now ranks 15/160 (Q1) in 'Medicine, General & Internal.'

Source: data according to Journal Citation Reports®, 2018 release, a Clarivate Analytics product.

MDPI will be attending Neuroscience 2019, to be held at McCormick Place in Chicago, IL, USA, 19–23 October 2019.

Join 30,000 colleagues from more than 70 countries at the world’s largest marketplace of ideas and tools for global neuroscience.

The following MDPI journals will be represented:

• Brain Sciences
• Journal of Clinical Medicine
• Genes
• Cancers
• Diagnostics
• Pathogens
• Medicines
• International Journal of Molecular Sciences
• Healthcare
• Journal of Personalized Medicine
• Psych
• Cells
• Children
• Biomedicines

If you are also attending this conference, please feel free to stop by our booth (Booth #405). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.sfn.org/Meetings/Neuroscience-2019.

MDPI will be attending the European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019.

The ESC Congress is the world’s largest conference in cardiovascular medicine. ESC Congress 2019 will take place in one of the world’s most alluring cities, Paris, and will be organised in conjunction with the World Heart Federation emphasizing the global reach of the event.

ESC Congress 2019 will build on the solid foundations of a congress that attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.

The following MDPI journals will be represented:

• Journal of Clinical Medicine
• Diagnostics
• Cancers
• Pathogens
• Cells
• Children
• Medicina
• Healthcare
• Journal of Personalized Medicine
• Journal of Cardiovascular Development and Disease
• Biomedicines

If you are also attending this conference, please feel free to stop by our booth (Booth C590). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: http://www.escexhibition.org/ESC2019/default.aspx.

MDPI will be attending the 52nd Annual Meeting of ESPGHAN, to be held in Glasgow, Scotland, 5–8 June 2019.

Every year the ESPGHAN Annual Meeting attracts the key opinion leaders in the field of Pediatric Gastroenterology, Hepatology and Nutrition from Europe and all around the world, making the congress the largest conference of its kind worldwide.

Attended by 4.600 participants from 100 countries, the previous 51st Annual Meeting in Geneva offered more than 950 abstract presenters a stage to publish their latest research results. Thus, the congress is a great opportunity to meet colleagues in your field from around the world and provides a unique platform to exchange new ideas and discuss the latest developments in these fields. In 2019, the scientific programme will once again include a wide range of sessions and symposia, a clinical track, postgraduate courses as well as the popular hands-on endoscopy learning zone.

The following MDPI journals will be represented:

• Nutrients
• Journal of Clinical Medicine
• Pathogens
• Diagnostics
• Medicines
• Healthcare

If you are also attending this conference, please feel free to stop by our booth (Booth #45). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.espghancongress.org/

MDPI will be attending the ESHG 2019, to be held in Gothenburg, Sweden, 15th-18th June 2019.

ESHG 2019 - The 53rd European Human Genetics Conference is everything you need in human genetics, whatever your professional background. The Scientific Program Committee (SPC) has worked hard to invite the best speakers from various sectors of human genetics, and to select the best abstracts for platform presentations.

The following MDPI journals will be represented:

• Genes
• Journal of Clinical Medicine
• Cancers
• International Journal of Molecular Sciences
• Cells
• Diagnostics
• Healthcare
• Journal of Personalized Medicine
• Genealogy
• Biomedicines

If you are also attending this conference, please feel free to stop by our booth (Booth #492). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.eshg.org/

Barcelona, Spain
27 September–1 October 2019

We will be attending the ESMO Congress 2019 in Barcelona, Spain from 27 September to 1 October 2019. The European Society for Medical Oncology (ESMO) is the leading European professional organization for medical oncology. Comprised of 17,000 oncology professionals from over 130 countries, they are the society of reference for oncology education and information. The annual ESMO Congress, which is held every year, is attended by 25,000 participants. The Congress presents the latest scientific developments in basic, translational and clinical cancer research and contextualizes new findings for practical implementation in everyday patient care. Representatives of the following MDPI open access journals will attend:

Cancers (https://www.mdpi.com/journal/cancers)

Diagnostics (https://www.mdpi.com/journal/diagnostics)

Genes (https://www.mdpi.com/journal/genes)

Healthcare (https://www.mdpi.com/journal/healthcare)

IJERPH (https://www.mdpi.com/journal/ijerph)

Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)

Journal of Personalized Medicine (https://www.mdpi.com/journal/jpm)

Medicina (https://www.mdpi.com/journal/medicina)

Medicines (https://www.mdpi.com/journal/medicines)

Vaccines (https://www.mdpi.com/journal/vaccines)

If you will attend this conference, please stop by our booth (Booth # P433). Our delegates look forward to meeting you in person and to answering any questions you may have concerning open access publishing and our journals.

For more information about the conference, please visit
https://www.esmo.org/Conferences/ESMO-Congress-2019

We will be attending the 46th Controlled Release Society Annual Meeting & Exposition. It is one of the biggest events in pharmaceutical field. Representatives of the following open access journals will attend:

Pharmaceutics
JCM
Biomolecules
Materials
IJMS
Molecules
Nanomaterials
Pharmaceuticals
Scientia Pharmaceutica
Vaccines
JPM
Genes
JFB
IJERPH
Biomedicines
Healthcare

If you are also attending this conference, please feel free to stop by our booth (Booth #303). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.controlledreleasesociety.org/

We are pleased to welcome more universities from Poland, Italy, Germany, Brazil and other parts of the world to MDPI's Institutional Open Access Program (IOAP). A warm welcome to the institutions listed below, who have joined the Program in February and March this year.

James Madison University (JMU), Harrisonburg	USA
Loughborough University	UK
Lublin University of Technology	Poland
Marquette University, Milwaukee	USA
Massey University, Palmerston North	New Zealand
Medical College of Wisconsin	USA
Nicolaus Copernicus University, Toruń	Poland
Poznań University of Life Sciences	Poland
Robert Koch-Institut, Berlin	Germany
Rothamsted Research, Harpenden	UK
Santa Clara University (SCU)	USA
Technical University of Applied Sciences Wildau	Germany
University of Aveiro	Portugal
University of Brasília	Brazil
University of Duisburg-Essen	Germany
University of Greifswald	Germany
University of Molise	Italy
University of Naples Parthenope	Italy
University of São Paulo (USP) - São Carlos Institute of Physics	Brazil
University of Szczecin	Poland
University of Warmia and Mazury, Olsztyn	Poland
University West, Trollhättan	Sweden
UTP University of Science and Technology, Bydgoszcz	Poland
VTT - Technical Research Centre of Finland	Finland

Authors affiliated with these institutions can now enjoy a discount on the APC for papers accepted for publication in any MDPI journal. If you would like to learn more about our program, please visit: https://www.mdpi.com/about/ioap or email us at [email protected].

We are delighted to announce our participation in Jisc’s Publication Router project, as of March 2019.

Publications Router is a Jisc service that automatically sends notifications about research articles to institutions' systems such as their repositories or CRISs, since May 2015. Through this agreement, MDPI will provide Jisc with daily feeds and information regarding published articles, which will be gathered by their system and delivered to institutions also registered to this service. Nearly all of our articles are published within 15 days of acceptance, so institutions will receive them quite promptly.

The feed will include the full text of the published version of record, with no embargo, so the articles can be exposed immediately for public view. They are accompanied by rich metadata, including confirmation of the immediate CC BY licence, minimising the need for any manual intervention or checking.

For more information about Publications Router, you may contact Jisc’s central helpdesk at [email protected]. For any queries about MDPI’s institutional agreements and collaborations, you may get in touch with MDPI’s Institutional Engagement team at [email protected], which would be very happy to hear from further UK institutions.

Rigorous peer-review is the cornerstone of high quality academic publishing. Over 97,000 scholars served as reviewers for MDPI journals in 2018. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list all reviewers’ names to express our gratitude. In addition, this year the “MDPI Top Reviewer Awards” are announced, to recognize the very best reviewers for their expertise, dedication, high quality, and timely review reports. We are pleased to announce the following winners of the 2018 MDPI Top Reviewer Awards:

• Ali Behnood
• Andrea Pezzuolo
• Angela Gorgoglione
• Anna D'Auria
• Antonio D'Andrea
• Azhar Abbas
• Bogdan Zagajewski
• Chunhui Chen
• Dominika Głąbska
• Dominika Guzek
• Dragan Pamucar
• Francisco J. G. Silva
• Frank Li
• Gianluca Serafini
• Gyorgy Szekely
• Haozhi Pan
• Helvi Heinonen-Tanski
• José Manuel Gómez-Soberón
• Kathy Lewis
• Klara Kosova
• Luis N. López De Lacalle
• M. Z. Naser
• Malwina Tytła
• Masoume Amirkhani
• Matteo Ghidelli
• Moretti Laura
• Petra Schneider
• Roberto Cerchione
• Spyros Papaefthymiou
• Ştefan Cristian Gherghina

Since 2010, MDPI has run its own online submission system. More recently, we have made the software, with accompanying publishing services, available to other publishers as JAMS (Journal and Article Management System). We are now delighted to announce the launch of JAMS Journals, a standardized platform for operating open access journals at low cost.

JAMS Journals provides a comprehensive service, including a shared submission website, journal websites hosted at a URL provided by the publisher, and a full production service. There is a small setup fee and the cost for each published paper is just a few hundred Swiss francs.

The platform demonstrates that running an open access journal can be straightforward and affordable. The JAMS Journals platform is suitable for

• small publishers or groups of scholars looking to launch their own journal;
• existing publishers or societies seeking to explore open access options;
• publishers looking to convert an existing subscription journal to open access.

JAMS journals launches with two journals from Canadian-based publisher Etcetera Publications:

• Canadian Journal of Pesticides & Pest Management (http://www.cjppm.ca)
• Nanotechnology in Agriculture, Food & Environment (http://www.nanoafe.ca)

Dr AJ Al-Rajab (President of Etcetera Publications) comments:

“In the past few months, we were working on our project to launch new open access scientific journals in the field of agricultural and environmental sciences. We decided to go with JAMS for this venture because of the high quality of their services, reasonable prices, professionalism and easy communication. Our portfolio is expected to grow rapidly during 2019 to include more titles covering different areas in agriculture and environment. MDPI earned already our complete satisfaction and we are looking for a long term cooperation.”

Alongside the new platform, we continue to provide flexible, tailored journal management solutions for existing publishers. For any questions or to request a quotation, contact Dr. Constanze Schelhorn ([email protected]).

2018 was a great year for preprints, with increasing numbers of authors looking to make their papers available online before peer review. Along with other preprint servers, our platform Preprints.org  saw an increase in the uptake from authors, and more than double the number of announced papers compared to 2017. In fact, we recently passed two important milestones: 8000 preprints online and 30,000 authors. 

We believe that the whole research community has the opportunity to benefit from work being available online as early as possible. We thank and congratulate our authors for supporting us to make this goal a reality.

In 2019, we will be looking carefully at how to provide better value for authors, maintain efficiency while growing in size, and make sure we remain well-connected with the research community. 

If you want to participate, you can consider screening preprints or joining our advisory board. And, of course, posting your own work.

We are delighted to announce the establishment of our national Open Access agreement with the Austrian Academic Library Consortium (KEMÖ) and the Austrian Science Fund (FWF). Through this national agreement, the Austrian institutions listed below as well as FWF will cover the Article Processing Charges (APC) of manuscripts published by eligible corresponding or funded authors in MDPI journals as long as central funds are available.

All participating institutions have gained access to the MDPI online submission system where they can find full article metadata and pricing information as well as Funder and Grant ID details for easy identification and additional transparency. At the same time eligible authors are benefited from an APC discount which comes at no cost for the institutions.

Eligible corresponding authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email address. To claim their discount, FWF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript. The institutions will then crosscheck the information and confirm the APC funding.

Eligible authors that have their APC covered by their institution or funder are advised to include the following sentence in their acknowledgments: "Open Access Funding by the [name of the institution/funder]".

The full text of the agreement is openly available online at: http://doi.org/10.5281/zenodo.2536007

For any questions about the agreement, please contact the KEMÖ Consortium at [email protected], FWF at [email protected], or the MDPI IOAP team at [email protected]

The Austrian institutions participating in this agreement are:

• Austrian Science Fund (FWF)
• University for Continuing Education Krems
• University of Applied Sciences BFI Vienna
• University of Applied Sciences Upper Austria
• University of Applied Sciences Technikum Wien
• Vorarlberg University of Applied Sciences
• International Institute for Applied Systems Analysis (IIASA)
• Institute of Science and Technology Austria
• MCI Management Center Innsbruck
• University of Graz
• University of Linz
• University of Salzburg
• Graz University of Technology
• TU Wien
• University of Veterinary Medicine Vienna
• University of Vienna

This is our first collective agreement with a national library consortium, while the individual institutions around the world participating in our IOAP are now more than 500 - see details here: https://www.mdpi.com/about/ioap. We would be mostly interested in discussing about possible collaborations with other consortia, funders, and institutions in our mutual efforts to accelerate Open Access.

We are pleased to announce the new platform Encyclopedia, which is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

We encourage authors of review articles to quote and adapt the content of their published papers to create Encyclopedia entries. You can create completely new entries on topics in which you have knowledge and expertise. There is no limit on the topics or research fields. All of science and the humanities are included. Each entry will be published directly after submission.

We also have prepared a DOI application function in Encyclopedia. Once a DOI application is approved, the entry website will announce the DOI number and a pdf version with DOI information will be automatically created.

We look forward to your contributions and hope you will make use of this service. Find more about the service at: https://encyclopedia.pub/

 

We are delighted to announce that the Bill and Melinda Gates Foundation (BMGF) is now a participant of our Institutional Open Access Program (IOAP). Authors funded by the BMGF can enjoy discounts on the APC, while the funder covers the costs of eligible articles centrally. BMGF also has access to the MDPI online submission system where they can find full article metadata and pricing information as well as Grant ID details for easy identification and additional transparency.

We hope that funded authors find the programme beneficial and we are happy to offer our IOAP to other funders that need a streamlined workflow of compliance checking and APC coverage. 

To claim their discount, BMGF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript.

For any questions about the BMGF agreement, please contact the funder at [email protected] or the MDPI IOAP team at [email protected].

This week, James P. Allison and Tasuku Honjo were awarded the 2018 Nobel prize in physiology or medicine "for their discovery of cancer therapy by inhibition of negative immune regulation." As early as the 1990s, both immunologists discovered proteins that act as brakes on the T cells, ensuring the regulation that keeps autoreactive T cells in check.

Subsequent research found that blocking these so-called immune checkpoints through the use of checkpoint inhibitors shows promising results for cancer treatment, by ramping up the body's immune system and causing a stronger attack against tumor cells. In immunotherapy, doctors now have a viable alternative to chemotherapy and radiotherapy in treating some types of cancer, especially at advanced stages of infestation and including metastasis, even though instances of autoimmune reaction in immunotherapy are not yet fully understood.

Recent research has been looking into the potential of inhibitors blocking PD-1, the T cell protein discovered by Tasuku Honjo in 1992. A group at University of Calgary "investigated the ability for immune checkpoint blockade to enhance the efficacy of oncolytic reovirus (RV) for the treatment of breast cancer" (article published by Ahmed A. Mostafa et al. in Cancers). Simona De Rosa et al. investigated PD-L1/PD-1 expression in gastric cancer cells (article here). One group in Nice, France, studied the characteristics of lung adenocarcinomas in elderly patients in another article published in Cancers.

Diagram depicting the anticancer mechanism of PD-1/PD-L1 inhibitors
(Source: Figure 1 in S.M. Abdin et al., Cancers 2018,
doi:10.3390/cancers10020032).

In an article published in the International Journal of Molecular Sciences (IJMS), Xin Sun et al. give "some structural guidance" for the design of an antibody effective in blocking the PD-L1 immune suppressor. Shifaa M. Abdin et al. provide an overview of checkpoint inhibitors in their review paper entitled "Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors" (Figure 1 to the right).

In order to improve response rates in patients, targeting additional checkpoints such as LAG-3, BTLA or TIM-3 may prove effective, as discussed in an IJMS review paper by Robert J. Torphy et al. Other studies are looking into resistance mechanisms in tumor cells. Once these mechanisms are better understood, adjuvant treatments can help "improve the efficacy of immunotherapy and [...] expand its scope" (review paper by J. Rieth and S. Subramanian: "Mechanisms of Intrinsic Tumor Resistance to Immunotherapy").

One more recent review paper entitled "Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses" (Teresa Nguyen et al.) lays out different strands of use of oncolytic viruses in cancer treatment, one of them being their combined use with checkpoint inhibitors.

A number of papers published in last year's Special Issue on "Targeting Immune Checkpoints and Immunotherapy" (guest-edited by Dr. William Chi-shing Cho) dealt with aspects of immunotherapy as well:

➤ "Targeting Immune Cell Checkpoints during Sepsis" (Naeem K. Patil et al.)
➤ "Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality" (Andreas Pircher et al.)
➤ "PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression"
(Michal Šmahel)
➤ "Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways" (Kai Li et al.)

If you are interested to publish your research on related topics, we welcome your submission to the Special Issue on "Signaling Pathways and Immune Checkpoint Regulation in Cancer" (guest-edited by Prof. Dr. Georgios Rassidakis) in our oncology journal Cancers.

  

Recently, it was announced that a group of European funders supported 10 principles that will help to expand open access, known as Plan S. MDPI warmly welcomes this move as a step towards achieving more open and accessible communication of research across all disciplines. Some aspects remain to be clarified, however the details given so far match the aims and values that MDPI has held over the past two decades.

We believe that open access publishers should be active participants in discussions around Plan S, particularly regarding potential new business models and practical aspects of implementation. MDPI supports APCs as a transparent unit of payment for article publishing, however we are committed to exploring other measures and recently signed the Jussieu Call. Sustainability is a key value for MDPI, and future funding models should have at their heart the sustainability of knowledge and research dissemination. Plan S provides an opportunity for funders and publishers to directly discuss funding of open access journals in ways that are beneficial to all parties involved.

We will be attending the 77th Annual Meeting of the Japanese Cancer Association in Osaka, Japan, 27–29 September 2018. The Japanese Cancer Association (JCA) is the oldest professional association related to cancer research in Japan. It focuses on all aspects of cancer research, including basic, clinical and translational research into the etiology, prevention, diagnosis, and treatment of cancer. More than 5,000 scientists and other cancer professionals attend the JCA Annual Meeting every year.

Representatives of the following MDPI open access journals will attend:

Cancers (https://www.mdpi.com/journal/cancers)
Antibodies (https://www.mdpi.com/journal/antibodies)
Diagnostics (https://www.mdpi.com/journal/diagnostics)
Healthcare (https://www.mdpi.com/journal/healthcare)
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)
Vaccines (https://www.mdpi.com/journal/vaccines)
Medicina (https://www.mdpi.com/journal/medicina)

If you are attending this conference, please stop by our booth (Booth # 3-25). Our delegates look forward to meeting you in person and answering any questions you may have concerning open access publishing and our journals.

For more information about the conference, please visit:
https://www.congre.co.jp/jca2018/index_en.php

We are happy to announce the establishment of an Open Access (OA) agreement with Qatar National Library (QNL). QNL is committed to supporting and helping Qatar authors publish OA at no cost. Through this national agreement, QNL will cover the Article Processing Charges (APC) of manuscripts published by Qatar-based corresponding authors in MDPI journals.

Eligible corresponding authors affiliated with Qatar research centers and universities are prompted to choose QNL as part of our Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email and/or a computer registered with the institution’s IP range. QNL will then crosscheck the information and confirm the APC funding.

Qatar authors that have their APC covered by QNL are advised to include the following sentence in their acknowledgments: "The publication of this article was funded by Qatar National Library".

For more information, please visit Open Access at QNL or email the QNL Open Access team at [email protected].

We will be attending the ESMO 2018 Congress in Munich, Germany from 19th to 23rd October 2018. The European Society for Medical Oncology (ESMO) is the leading European professional organization for medical oncology. Comprising 18,000 oncology professionals from over 150 countries, they are the society of reference for oncology education and information. The ESMO 2018 Congress will provide a scientific and educational program able to directly impact the daily clinical practice of oncologists. This year, the program also features a dedicated nursing track through a collaboration with the European Oncology Nursing Society (EONS). Representatives of the following MDPI open access journals will attend:

Cancers (https://www.mdpi.com/journal/cancers)
Antibodies (https://www.mdpi.com/journal/antibodies)
Epigenomes (https://www.mdpi.com/journal/epigenomes)
Healthcare (https://www.mdpi.com/journal/healthcare)
High-Throughput (https://www.mdpi.com/journal/high-throughput)
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)
Journal of Personalized Medicine (https://www.mdpi.com/journal/jpm)
Medical Sciences (https://www.mdpi.com/journal/medsci)
Medicina (https://www.mdpi.com/journal/medicina)
Medicines (https://www.mdpi.com/journal/medicines)
Vaccines (https://www.mdpi.com/journal/vaccines)

If you are attending this conference, please stop by our booth (Booth # P106). Our delegates look forward to meeting you in person and answering any questions you may have concerning open access publishing and our journals.

For more information about the conference, please visit:
http://www.esmo.org/Conferences/ESMO-2018-Congress

 

We are pleased to announce that the Journal of Clinical Medicine (JCM) has received a first Impact Factor in the latest edition of the Journal Citation Reports®, published by Clarivate Analytics in June 2018.

JCM is covered in the Science Citation Index Expanded (SCIE) in Web of Science and received a first Impact Factor of 5.583. The journal ranks 15/154 (Q1) in 'Medicine, General & Internal.'

The Journal Citation Reports®, 2018 release, is a Clarivate Analytics product.

We will be attending the 18th World Congress of Basic and Clinical Pharmacology, which will be held in Kyoto, Japan, 1–6 July 2018, and representing the following open access journals:

JCM
Pharmaceuticals
Biomedicines
Brain Sciences
Diseases
Pharmacy
Tropical Medicine and Infectious Disease
Cancers
Marine Drugs

Please come along to our booth (#3-6) to chat with our delegates about our journals. We'll gladly answer any questions about our journals and about open access publishing. We look forward to meeting you in person in Edmonton!

For more information on the conference, please visit:
http://www.wcp2018.org/

We are pleased to report the Journal of Clinical Medicine (JCM) received a CiteScore of 7.07 for 2017. The metric reflects citation activity in 2017 in Scopus for papers published in the period 2014‒2016.

JCM ranks 10th out of 841 in the 'General Medicine' category.

For the full details in the current CiteScore release, please see the journal's Source profile. To check the full list of MDPI journals receiving CiteScores, please see here.

The 2017 CiteScore™ data is available now, based on citation data in the Scopus® database. The current CiteScore reflects citation activity in 2017 for articles published in 2014‒2016. Please note that the list below includes journals assigned a CiteScore in this year’s release. For a full list of journals indexed in Scopus, please see our journal list.

Thirteen of our journals received a CiteScore which is in the top 10% of the distribution in at least one of the categories (marked with * in the table below), while a further 32 journals exhibit scores that are in the first quartile of the respective categories.

To access the full data for MDPI journals, please see here. More data can also be found in SJR Scimago Journal & Country Rank.

Unlike CiteScores and the widely used Journal Impact Factors, the Source Normalized Impact per Paper (SNIP) metrics are normalized in order to correct for differences in citation practices between scientific fields. Therefore, the SNIP allows direct comparison between journals specialized in different fields.

According to 2017 data, MDPI publishes six journals with an average citation impact, or SNIP, in excess of 1.500. These journals are Biomolecules, Cancers, Journal of Clinical Medicine (JCM), Marine Drugs, Remote Sensing and Sensors (see the last column in the table below).

CiteScore Data for MDPI Journals

Journal	Rank (Quartile)	Category	Link	CiteScore 2017	2016	2015	SNIP 2017
Aerospace	43/116 (Q2)	• Aerospace Engineering	Link	1.23	-	-	1.152
Agriculture	69/309 (Q1) 91/398 (Q1) 78/255 (Q2)	• Agronomy and Crop Science • Plant Science • Food Science	Link	1.93	-	-	1.133
Agronomy	46/309 (Q1)	• Agronomy and Crop Science	Link	2.38	-	-	1.115
Algorithms	22/46 (Q2) 61/125 (Q2) 60/107 (Q3) 64/114 (Q3)	• Numerical Analysis • Computational Mathematics • Computational Theory and Mathematics • Theoretical Computer Science	Link	1.03	1.15	1.07	0.749
Animals	12/154 (Q1) * 48/367 (Q1)	• General Veterinary • Animal Science and Zoology	Link	2.02	1.46	1.66	1.099
Antibiotics	6/68 (Q1) * 62/263 (Q1) 55/230 (Q1) 31/108 (Q2) 47/134 (Q2) 139/398 (Q2)	• General Pharmacology, Toxicology and Pharmaceutics • Infectious Diseases • Pharmacology (medical) • Microbiology (medical) • Microbiology • Biochemistry	Link	2.85	1.65	-	0.975
Antibodies	43/143 (Q2) 61/164 (Q2) 85/189 (Q2)	• Drug Discovery • Immunology and Allergy • Immunology	Link	2.85	-	-	0.844
Antioxidants	23/119 (Q1) 35/169 (Q2) 100/398 (Q2) 119/367 (Q2) 102/264 (Q2)	• Clinical Biochemistry • Physiology • Biochemistry • Molecular Biology • Cell Biology	Link	3.42	-	-	1.361
Applied Sciences	48/270 (Q1) 15/66 (Q1) 31/116 (Q2) 18/53 (Q2) 151/434 (Q2) 186/535 (Q2)	• General Engineering • Fluid Flow and Transfer Processes • Instrumentation • Process Chemistry and Technology • General Materials Science • Computer Science Applications	Link	1.90	-	-	0.801
Biology	12/177 (Q1)* 32/186 (Q1) 10/40 (Q1)	• General Agricultural and Biological Sciences • General Biochemistry, Genetics and Molecular Biology • General Immunology and Microbiology	Link	3.48	3.02	2.78	0.961
Biomolecules	31/398 (Q1) * 41/367 (Q1)	• Biochemistry • Molecular Biology	Link	5.72	1.67	3.08	1.542
Biosensors	20/119 (Q1)	• Clinical Biochemistry	Link	3.59	2.83	2.37	1.122
Brain Sciences	47/111 (Q2)	• General Neuroscience	Link	2.56	-	-	0.695
Cancers	26/323 (Q1) * 23/191 (Q1)	• Oncology • Cancer Research	Link	5.82	5.02	4.07	1.567
Catalysts	32/151 (Q1) 21/46 (Q2)	• Physical and Theoretical Chemistry • Catalysis	Link	3.23	3.44	3.45	0.954
Crystals	76/272 (Q2) 140/434 (Q2) 127/398 (Q2) 26/64 (Q2)	• General Chemical Engineering • General Materials Science • Condensed Matter Physics • Inorganic Chemistry	Link	1.97	1.89	1.47	0.745
Diagnostics	49/119 (Q2)	• Clinical Biochemistry	Link	2.43	-	-	0.788
Diversity	30/124 (Q1) 14/52 (Q2) 83/306 (Q2) 11/29 (Q2)	• Nature and Landscape Conservation • Agricultural and Biological Sciences (miscellaneous) • Ecology • Ecological Modelling	Link	2.15	2.03	1.96	1.300
Electronics	109/644 (Q1) 26/148 (Q1) 42/224 (Q1) 50/259 (Q1) 23/96 (Q1)	• Electrical and Electronic Engineering • Hardware and Architecture • Control and Systems Engineering • Computer Networks and Communications • Signal Processing	Link	2.97	-	-	1.227
Energies	6/73 (Q1) * 31/192 (Q1) 103/644 (Q1) 4/16 (Q1) 47/140 (Q2)	• Control and Optimization • Energy Engineering and Power Technology • Electrical and Electronic Engineering • Energy (miscellaneous) • Renewable Energy, Sustainability and the Environment	Link	3.11	2.50	2.87	1.340
Entropy	35/202 (Q1)	• General Physics and Astronomy	Link	2.41	1.87	1.99	1.189
Forests	17/129 (Q1)	• Forestry	Link	2.31	2.06	1.76	0.990
Future Internet	132/259 (Q3)	• Computer Networks and Communications	Link	1.25	-	-	-
Games	132/187 (Q3) 78/110 (Q3) 305/418 (Q3)	• Statistics and Probability • Statistics, Probability and Uncertainty • Applied Mathematics	Link	0.61	0.87	0.57	1.038
Genes	21/91 (Q1) 74/311 (Q1)	• Genetics (clinical) • Genetics	Link	3.49	3.62	3.18	0.374
Geosciences	32/182 (Q1)	• General Earth and Planetary Sciences	Link	1.97	1.67	1.29	0.856
Information	143/251 (Q3)	• Information Systems	Link	1.16	0.78	0.94	1.146
Insects	27/135 (Q1)	• Insect Science	Link	1.85	1.81	1.38	0.719
International Journal of Environmental Research and Public Health (IJERPH)	80/478 (Q1) 34/106 (Q2)	• Public Health, Environmental and Occupational Health • Health, Toxicology and Mutagenesis	Link	2.41	2.38	2.42	0.931
International Journal of Molecular Sciences (IJMS)	7/69 (Q1) * 61/535 (Q1) 20/163 (Q1) 9/64 (Q1) 26/151 (Q1) 89/367 (Q2) 17/46 (Q2)	• Spectroscopy • Computer Science Applications • Organic Chemistry • Inorganic Chemistry • Physical and Theoretical Chemistry • Molecular Biology • Catalysis	Link	3.86	3.73	3.37	0.998
ISPRS International Journal of Geo-Information (IJGI)	79/605 (Q1) 22/82 (Q2) 13/36 (Q2)	• Geography, Planning and Development • Earth and Planetary Sciences (miscellaneous) • Computers in Earth Sciences	Link	2.10	1.62	1.52	1.062
Journal of Clinical Medicine (JCM)	10/841 (Q1) *	• General Medicine	Link	7.07	-	-	1.535
Journal of Functional Biomaterials (JFB)	43/199 (Q1) 23/77 (Q2)	• Biomedical Engineering • Biomaterials	Link	3.47	-	-	1.344
Journal of Low Po- wer Electronics and Applications (JLPEA)	301/644 (Q2)	• Electrical and Electronic Engineering	Link	1.12	0.98	0.83	0.367
Journal of Personalized Medicine (JPM)	54/189 (Q2)	• Medicine (miscellaneous)	Link	2.61	-	-	0.944
Land	50/124 (Q2) 129/306 (Q2) 36/65 (Q3)	• Nature and Landscape Conservation • Ecology • Global and Planetary Change	Link	1.44	-	-	0.658
Life	4/94 (Q1) * 70/561 (Q1) 40/186 (Q1) 20/80 (Q2)	• Palaeontology • Ecology, Evolution, Behavior and Systematics • General Biochemistry, Genetics and Molecular Biology • Space and Planetary Science	Link	3.16	2.95	1.68	0.935
Marine Drugs	17/146 (Q1)	• Drug Discovery	Link	4.58	3.83	3.66	1.537
Materials	83/434 (Q1)	• General Materials Science	Link	3.02	3.26	3.11	1.285
Membranes	5/18 (Q2) 15/53 (Q2) 4/10 (Q2)	• Chemical Engineering (miscellaneous) • Process Chemistry and Technology • Filtration and Separation	Link	2.69	2.19	2.95	0.880
Metabolites	47/209 (Q1) 103/398 (Q2) 127/367 (Q2)	• Endocrinology, Diabetes and Metabolism • Biochemistry • Molecular Biology	Link	3.35	-	-	0.925
Metals	155/434 (Q2)	• General Materials Science	Link	1.87	-	-	0.955
Micromachines	105/554 (Q1) 154/644 (Q1) 64/224 (Q2)	• Mechanical Engineering • Electrical and Electronic Engineering • Control and Systems Engineering	Link	2.31	1.83	1.78	0.987
Minerals	33/175 (Q1) 45/208 (Q1)	• Geotechnical Engineering and Engineering Geology • Geology	Link	2.21	2.13	1.77	1.149
Molecules	4/25 (Q1) 25/172 (Q1) 18/104 (Q1) 31/163 (Q1) 30/151 (Q1) 31/146 (Q1) 55/160 (Q2)	• Chemistry (miscellaneous) • Pharmaceutical Science • Analytical Chemistry • Organic Chemistry • Physical and Theoretical Chemistry • Drug Discovery • Molecular Medicine	Link	3.27	3.09	2.65	1.146
Nutrients	11/255 (Q1) * 9/112 (Q1) *	• Food Science • Nutrition and Dietetics	Link	4.35	4.29	4.07	1.403
Pathogens	38/263 (Q1) 20/108 (Q1) 9/40 (Q1) 40/164 (Q1) 110/367 (Q2)	• Infectious Diseases • Microbiology (medical) • General Immunology and Microbiology • Immunology and Allergy • Molecular Biology	Link	3.52	-	-	1.166
Pharmaceuticals	14/172 (Q1) * 33/160 (Q1)	• Pharmaceutical Science • Molecular Medicine	Link	4.12	4.90	3.64	1.370
Pharmaceutics	21/172 (Q1)	• Pharmaceutical Science	Link	3.68	3.83	2.68	1.092
Photonics	30/116 (Q1) 80/270 (Q2) 53/160 (Q2)	• Instrumentation • Radiology Nuclear Medicine and Imaging • Atomic and Molecular Physics, and Optics	Link	1.96	-	-	0.817
Plants	73/561 (Q1) 48/389 (Q1) 44/306 (Q1)	• Ecology, Evolution, Behavior and Systematics • Plant Science • Ecology	Link	3.13	-	-	0.969
Polymers	17/142 (Q1) 63/359 (Q1)	• Polymers and Plastics • General Chemistry	Link	3.30	3.74	3.37	1.213
Religions	26/389 (Q1) *	• Religious Studies	Link	0.56	-	-	0.676
Remote Sensing	13/182 (Q1) *	• General Earth and Planetary Sciences	Link	4.03	3.56	3.76	1.559
Resources	19/142 (Q1) 39/261 (Q1)	• Nature and Landscape Conservation • Management, Monitoring, Policy and Law	Link	2.69	-	-	1.387
Scientia Pharmaceutica	92/172 (Q3)	• Pharmaceutical Science	Link	0.86	-	-	0.513
Sensors	9/116 (Q1) * 25/160 (Q1) 100/644 (Q1) 19/104 (Q1) 113/398 (Q2)	• Instrumentation • Atomic and Molecular Physics, and Optics • Electrical and Electronic Engineering • Analytical Chemistry • Biochemistry	Link	3.23	2.78	2.21	1.550
Social Sciences	81/213 (Q2)	• General Social Sciences	Link	0.60	-	-	0.445
Sustainability	61/605 (Q1) * 55/261 (Q1) 60/140 (Q2)	• Geography, Planning and Development • Management, Monitoring, Policy and Law • Renewable Energy, Sustainability and the Environment	Link	2.37	1.96	1.78	1.030
Symmetry	44/327 (Q1) 17/45 (Q2) 16/40 (Q2) 14/25 (Q2)	• General Mathematics • Computer Science (miscellaneous) • Physics and Astronomy (miscellaneous) • Chemistry (miscellaneous)	Link	1.32	1.12	0.95	0.802
Toxins	18/106 (Q1) 21/111 (Q1)	• Health, Toxicology and Mutagenesis • Toxicology	Link	3.32	3.34	3.76	1.136
Vaccines	5/230 (Q1) * 13/263 (Q1) * 18/302 (Q1) * 11/146 (Q1) * 32/189 (Q1)	• Pharmacology (medical) • Infectious Diseases • Pharmacology • Drug Discovery • Immunology	Link	4.88	1.23	3.76	1.255
Viruses	29/263 (Q1) 16/68 (Q1)	• Virology • Infectious Diseases	Link	3.88	3.60	3.74	1.130
Water	66/605 (Q1) 37/191 (Q1) 43/199 (Q1) 193/398 (Q2)	• Geography, Planning and Development • Water Science and Technology • Aquatic Science • Biochemistry	Link	2.29	2.05	1.96	1.007

MDPI will be attending ASM Microbe 2018 International Conference during the three day event held from 8–10 June.

ASM Microbe showcases the best microbial sciences in the world and provides a one-of-a-kind forum to explore the complete spectrum of microbiology, from basic science to translation and application. Representatives of the following open access journals will attend:

Toxins
Journal of Clinical Medicine
Viruses
Antibiotics
Diseases
Medicines
Fermentation
Veterinary Sciences
Genes
International Journal of Environmental Research and Public Health (IJERPH)
Pathogens
Tropical Medicine and Infectious Disease
Vaccines
Microorganisms

If you are also attending this conference, please stop by our Booth: #731. Our delegates look forward to meeting you in person, to answer any questions you may have regarding open access publication and our journals. For more information about the conference, please visit: https://www.asm.org/index.php/asm-microbe-2018.

Date: 8–10 June 2018
Location: Georgia World Congress Center, 285 Andrew Young International Blvd NW, Atlanta, GA 30313, USA

We are pleased to announce the results of the first MDPI Writing Prize. We received a large number of entries from across the globe on the theme of “The Global Benefits of Open Research”. It was a pleasure to read so many original, well-researched and well-presented ideas, and the final choice was not an easy one. We are pleased to announce that the winners are as follows:

1st prize (500 CHF, Swiss knife and certificate)

Edmond Sanganyado, Shantou University, China

2nd prizes (250 CHF, Swiss knife and certificate)

Kamala T. Rajahgopal, Asia e University, Malaysia
Yin Zhixuan, Qingdao University of Technology, China

3rd prizes (100 CHF, Swiss knife and certificate)

Alexandra Ticea, Carol Davila University of Medicine and Pharmacy, Romania
Ankur Sarker, University of Virginia, USA
Daniel Attoye, United Arab Emirates University, UAE

Congratulations to all of them! The winning entries can be downloaded by clicking on the names above. A compilation of all entries will soon be available as an open access book.

The writing prize is sponsored by the MDPI English editing service.

At MDPI, we always want to keep you up to date. Even for already published articles, some corrections or minor changes may occur. To prevent you from missing any updates, from now on you will be able to access the latest version of any manuscript by clicking on the “check for updates” logo that you can find in the PDF file, even if you have saved the file on your computer.

We are proud to announce that MDPI is now a member of UKSG, the UK´s largest scholarly communications community. Through UKSG, different stakeholders share their knowledge and experience in order to improve the knowledge and information environment for researchers. UKSG´s members include universities, publishers, content providers, intermediaries, and other similar organisations. Members participate in discussions and events on issues around scholarly communications.

The UKSG Annual Conference and Exhibition is a flagship initiative from the UKSG and one of the most stimulating events in the scholarly communications calendar. It is held annually and attracts a large number of delegates. More information is available at https://www.uksg.org/events/annualconference

MDPI is delighted to be a part of this active community and we look forward to making our own contribution. We will continue to support organisations and initiatives that boost collaboration and vision within scholarly communication.

More information about UKSG can be found at https://www.uksg.org/. The full membership list is available at: https://www.uksg.org/members.

The DORA initiative addresses the need for advanced approaches in the evaluation and measurement of the quality of scientific research outputs. It is a worldwide initiative covering all scholarly disciplines. MDPI proudly joins a list of more than 400 organizations around the world which support DORA’s recommendations for improving the way the quality of research results is evaluated.

More info can be found at http://www.ascb.org/dora/

MDPI will be attending the Experimental Biology 2018 annual meeting in San Diego, CA, USA from 21 to 25 April 2018, representing the following open access journals:

Antibiotics
Antioxidants
Behavioral Sciences
Bioengineering
Biology
Biomedicines
Brain Sciences
Cancers
Cells
Dentistry Journal
Diagnostics
Diseases
Epigenomes
Fermentation
Genes
High-Throughput
International Journal of Molecular Sciences (IJMS)
International Journal of Environmental Research and Public Health (IJERPH)
Journal of Clinical Medicine (JCM)
Journal of Developmental Biology (JDB)
Journal of Functional Morphology and Kinesiology (JFMK)
Metabolites
Methods and Protocols
Microorganisms
Non-Coding RNA
Nutrients
Pharmaceuticals
Pharmaceutics
Proteomes
Sports
Veterinary Sciences
Viruses

Experimental Biology is the annual meeting of five societies comprised of more than 14,000 scientists and 25 guest societies.

The areas of primary focus include anatomy; biochemistry and molecular biology; investigative pathology; nutrition; pharmacology; physiology. Attendees represent scientists from academic institutions, government agencies, non-profit organizations and industry.

Conference details:
San Diego Convention Center
San Diego CA
USA
21­–25 April 2018

Do you want to learn more about MDPI open access journals? Don’t miss this opportunity to discuss them with our editors and MDPI delegates. If you are at Experimental Biology 2018, just come visit our booth for a moment to have a chat. We have some gifts for you to take home and will answer any questions that you have about the open access journal (booth # 1034).

For more information, please visit:
http://experimentalbiology.org/2018/Home.aspx